{"text": "Patient 20 was evaluated for Circulating hepatic transaminase concentrations were elevated. The patient also presented with parkinsonism and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 90, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 182, "label": "HPO_TERM"}, {"start": 213, "end": 217, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 21 includes abnormal thalamic signal intensity and eyelids were positioned lower than normal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 22 includes COX-deficient muscle fibers and abnormal thalamic signal intensity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 111, "label": "HPO_TERM"}, {"start": 137, "end": 141, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 23, who has a history of seizure-like activity. Examination also revealed a parkinsonian syndrome. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 24, who has a history of bilateral ptosis. Examination also revealed cytochrome c oxidase-negative muscle fibers. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "Patient 25 was evaluated for an increased lactate level. The patient also presented with an adult onset and slowness of movement and a resting tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 101, "label": "HPO_TERM"}, {"start": 106, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 26, a patient with a pediatric-onset disorder. Further investigation showed slurred, consistent with dysarthria and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 27 were a buildup of lactate in his bloodstream and a clinical syndrome resembling Parkinson's disease. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 133, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 28, who has a history of an increased lactate level. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 78, "label": "HPO_TERM"}, {"start": 106, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient 29 was evaluated for an adult onset. The patient also presented with features of parkinsonism and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 30, a patient with a pediatric-onset disorder. Further investigation showed a deficiency in cytochrome c oxidase and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 171, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 31, a patient with drooping of both upper eyelids. Further investigation showed unclear or mumbled speech and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 32 were a seizure and a parkinsonian syndrome. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 33, who has a history of slowness of movement and a resting tremor. Examination also revealed unclear or mumbled speech. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 34 includes epilepsy and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "Patient 35 was evaluated for a pediatric-onset disorder. The patient also presented with slurred, consistent with dysarthria and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 36, a patient with a clinical syndrome resembling Parkinson's disease. Further investigation showed a parkinsonian syndrome and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 190, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 37 were a condition that affects the muscles used for speech and epilepsy. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 38 includes a pediatric-onset disorder and motor speech difficulties. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 39 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 40 includes an increased lactate level and slurred, consistent with dysarthria. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 41, a patient with a late-onset variant of the condition. Further investigation showed an increased lactate level and hyperlactatemia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 84, "label": "HPO_TERM"}, {"start": 115, "end": 138, "label": "HPO_TERM"}, {"start": 143, "end": 157, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient 42 was evaluated for an increased lactate level. The patient also presented with a buildup of lactate in his bloodstream and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 43, a patient with a seizure. Further investigation showed a buildup of lactate in his bloodstream and a parkinsonian syndrome. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 56, "label": "HPO_TERM"}, {"start": 87, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient 44 was evaluated for drooping of both upper eyelids. The patient also presented with an increased lactate level and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 45 were a clinical syndrome resembling Parkinson's disease and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient 46 was evaluated for bilateral ptosis. The patient also presented with an increased lactate level and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "Patient 47 was evaluated for a seizure. The patient also presented with an atypical thalamic signal and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "Patient 48 was evaluated for slurred, consistent with dysarthria. The patient also presented with hyperlactatemia and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 49 were bilateral ptosis and a seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 73, "label": "HPO_TERM"}, {"start": 99, "end": 103, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 50 were an atypical thalamic signal and drooping of both upper eyelids. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 51, a patient with a pediatric-onset disorder. Further investigation showed drooping of both upper eyelids and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 52 includes a clinical syndrome resembling Parkinson's disease and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 53 were bilateral ptosis and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 81, "label": "HPO_TERM"}, {"start": 107, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 54, a patient with a late-onset variant of the condition. Further investigation showed signs of parkinsonism and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 84, "label": "HPO_TERM"}, {"start": 115, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 165, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 55, who has a history of an elevated hepatic transaminase concentration. Examination also revealed signs of parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient 56 was evaluated for an atypical thalamic signal. The patient also presented with slurred, consistent with dysarthria and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 57 includes hyperlactatemia and a late-onset variant of the condition. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 58 includes an increased lactate level and a buildup of lactate in his bloodstream. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 59, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed slowness of movement and a resting tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 168, "label": "HPO_TERM"}, {"start": 223, "end": 227, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 60 includes a pediatric-onset disorder and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 61 were an adult onset and an increased lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient 62 was evaluated for a seizure disorder. The patient also presented with an increased lactate level and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 63 were bilateral ptosis and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "Patient 64 was evaluated for parkinsonism. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 65, a patient with disease manifestation was in the pre-adolescent period. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 156, "label": "HPO_TERM"}, {"start": 161, "end": 186, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 66 were a condition that affects the muscles used for speech and bradykinesia and rigidity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient 67 was evaluated for an atypical thalamic signal. The patient also presented with a buildup of lactate in his bloodstream and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 68, who has a history of an atypical thalamic signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "Patient 69 was evaluated for an atypical thalamic signal. The patient also presented with a pediatric-onset disorder and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 70 were a parkinsonian syndrome and a clinical syndrome resembling Parkinson's disease. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 71 includes a buildup of lactate in his bloodstream and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "Patient 72 was evaluated for an adult onset. The patient also presented with hyperlactatemia and a condition that affects the muscles used for speech. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 73 includes a seizure and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 54, "label": "HPO_TERM"}, {"start": 59, "end": 74, "label": "HPO_TERM"}, {"start": 100, "end": 104, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 74, a patient with an increased lactate level. Further investigation showed hyperlactatemia and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 70, "label": "HPO_TERM"}, {"start": 101, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 145, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 75, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 76, who has a history of hyperlactatemia. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 112, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "Patient 77 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient 78 was evaluated for slurred, consistent with dysarthria. The patient also presented with a diagnosis of a seizure disorder and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 79, a patient with an atypical thalamic signal. Further investigation showed bilateral ptosis and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 144, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 80 includes signs of parkinsonism and a seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 81 were an abnormal thalamic MRI signal and an atypical thalamic signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 82 includes a clinical syndrome resembling Parkinson's disease and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 83, who has a history of an abnormal thalamic MRI signal. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 84, "label": "HPO_TERM"}, {"start": 112, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 84, who has a history of an elevated hepatic transaminase concentration. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 164, "label": "HPO_TERM"}, {"start": 219, "end": 223, "label": "GENE_VARIANT"}]}
{"text": "Patient 85 was evaluated for a condition that affects the muscles used for speech. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 80, "label": "HPO_TERM"}, {"start": 114, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "Patient 86 was evaluated for an adult onset. The patient also presented with a buildup of lactate in his bloodstream and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient 87 was evaluated for bradykinesia and rigidity. The patient also presented with a pediatric-onset disorder and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 132, "label": "HPO_TERM"}, {"start": 163, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 88 were hyperlactatemia and a seizure disorder. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 89, who has a history of a seizure disorder. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 90, a patient with a pediatric-onset disorder. Further investigation showed unclear or mumbled speech and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 149, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient 91 was evaluated for an atypical thalamic signal. The patient also presented with an elevated hepatic transaminase concentration and bilateral ptosis. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 151, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "Patient 92 was evaluated for an adult onset. The patient also presented with a seizure disorder and slurred, consistent with dysarthria. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 93 were a seizure disorder and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 94 includes a seizure disorder and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 95 were a buildup of lactate in his bloodstream and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 96, a patient with a condition that affects the muscles used for speech. Further investigation showed an atypical thalamic signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 154, "label": "HPO_TERM"}, {"start": 159, "end": 201, "label": "HPO_TERM"}, {"start": 225, "end": 229, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 97, who has a history of an elevated hepatic transaminase concentration. Examination also revealed poor articulation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 98, who has a history of a seizure. Examination also revealed poor articulation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 109, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 99, a patient with an adult onset. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 152, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient 100 was evaluated for a seizure. The patient also presented with an increased lactate level and a late-onset variant of the condition. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 101, who has a history of an elevated level of lactate in the blood. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 102, a patient with bilateral ptosis. Further investigation showed signs of parkinsonism and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 103, who has a history of an atypical thalamic signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 104 includes an increased lactate level and a pediatric-onset disorder. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 105, who has a history of epilepsy. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 106, a patient with hyperlactatemia. Further investigation showed an elevated level of lactate in the blood and a clinical syndrome resembling Parkinson's disease. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 182, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "Patient 107 was evaluated for a buildup of lactate in his bloodstream. The patient also presented with an elevated hepatic transaminase concentration and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient 108 was evaluated for an adult onset. The patient also presented with a clinical syndrome resembling Parkinson's disease and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 109 includes an adult onset and an increased lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "Patient 110 was evaluated for unclear or mumbled speech. The patient also presented with hyperlactatemia and a condition that affects the muscles used for speech. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient 111 was evaluated for an atypical thalamic signal. The patient also presented with an adult onset and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 112 includes an abnormal thalamic MRI signal and poor articulation. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "Patient 113 was evaluated for an adult onset. The patient also presented with an abnormal thalamic MRI signal and poor articulation. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 114, a patient with an adult onset. Further investigation showed a buildup of lactate in his bloodstream and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 167, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 115, who has a history of an atypical thalamic signal. Examination also revealed parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 121, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 116, who has a history of drooping of both upper eyelids. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 117 were a buildup of lactate in his bloodstream and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 118 were an adult onset and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "Patient 119 was evaluated for an atypical thalamic signal. The patient also presented with an abnormal thalamic MRI signal and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 120 includes a buildup of lactate in his bloodstream and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 121, a patient with a pediatric-onset disorder. Further investigation showed a buildup of lactate in his bloodstream and hyperlactatemia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 122 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "Patient 123 was evaluated for an adult onset. The patient also presented with an atypical thalamic signal and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 124, who has a history of poor articulation. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 125, a patient with an atypical thalamic signal. Further investigation showed an adult onset and drooping of both upper eyelids. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 126, a patient with unclear or mumbled speech. Further investigation showed an elevated hepatic transaminase concentration and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 166, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 127, who has a history of an elevated level of lactate in the blood. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 128, who has a history of signs of parkinsonism. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 119, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 129 includes a seizure and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 55, "label": "HPO_TERM"}, {"start": 60, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "Patient 130 was evaluated for drooping of both upper eyelids. The patient also presented with an atypical thalamic signal and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 131, who has a history of an elevated level of lactate in the blood. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient 132 was evaluated for signs of parkinsonism. The patient also presented with hyperlactatemia and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 112, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient 133 was evaluated for an atypical thalamic signal. The patient also presented with bilateral ptosis and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 134, who has a history of an atypical thalamic signal. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 135, a patient with a seizure disorder. Further investigation showed an increased lactate level and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 136 were a pediatric-onset disorder and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 137, who has a history of an atypical thalamic signal. Examination also revealed drooping of both upper eyelids. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 138 were an atypical thalamic signal and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 139, a patient with poor articulation. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 65, "label": "HPO_TERM"}, {"start": 96, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 124, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 140, a patient with hyperlactatemia. Further investigation showed a clinical syndrome resembling Parkinson's disease and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 141, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 142 were an elevated hepatic transaminase concentration and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 143 includes an elevated level of lactate in the blood and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 144, a patient with an abnormal thalamic MRI signal. Further investigation showed an adult onset and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 145 includes hyperlactatemia and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "Patient 146 was evaluated for poor articulation. The patient also presented with an elevated hepatic transaminase concentration and a seizure disorder. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 147 includes a buildup of lactate in his bloodstream and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 148, who has a history of an increased lactate level. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 149 were unclear or mumbled speech and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 150, a patient with a late-onset variant of the condition. Further investigation showed an atypical thalamic signal and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 166, "label": "HPO_TERM"}, {"start": 190, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 151 includes a seizure and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 55, "label": "HPO_TERM"}, {"start": 60, "end": 75, "label": "HPO_TERM"}, {"start": 101, "end": 105, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 152, who has a history of hyperlactatemia. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 153, who has a history of a seizure disorder. Examination also revealed slurred, consistent with dysarthria. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 154, a patient with a pediatric-onset disorder. Further investigation showed hyperlactatemia and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 155, a patient with an elevated hepatic transaminase concentration. Further investigation showed a pediatric-onset disorder and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 90, "label": "HPO_TERM"}, {"start": 121, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 156, a patient with an increased lactate level. Further investigation showed an atypical thalamic signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient 157 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 158, a patient with a seizure. Further investigation showed hyperlactatemia and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 57, "label": "HPO_TERM"}, {"start": 88, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 122, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 159 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 160 were an atypical thalamic signal and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 161, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 151, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 162 includes an adult onset and an abnormal thalamic MRI signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 163, a patient with a seizure. Further investigation showed an elevated hepatic transaminase concentration and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 57, "label": "HPO_TERM"}, {"start": 88, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 164, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 164, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 102, "label": "HPO_TERM"}, {"start": 130, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 165, who has a history of a buildup of lactate in his bloodstream. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 166 were a condition that affects the muscles used for speech and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 167, a patient with an abnormal thalamic MRI signal. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 136, "label": "HPO_TERM"}, {"start": 160, "end": 164, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 168 includes an elevated level of lactate in the blood and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 169, a patient with a buildup of lactate in his bloodstream. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 177, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 170 includes a seizure disorder and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 171 includes a seizure disorder and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 172, who has a history of an abnormal thalamic MRI signal. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient 173 was evaluated for an increased lactate level. The patient also presented with an elevated level of lactate in the blood and drooping of both upper eyelids. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 174 were signs of parkinsonism and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "Patient 175 was evaluated for an atypical thalamic signal. The patient also presented with poor articulation and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 176 includes an elevated level of lactate in the blood and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient 177 was evaluated for a seizure. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 123, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "Patient 178 was evaluated for slurred, consistent with dysarthria. The patient also presented with an elevated hepatic transaminase concentration and a seizure disorder. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 179, a patient with a buildup of lactate in his bloodstream. Further investigation showed an elevated level of lactate in the blood and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 156, "label": "HPO_TERM"}, {"start": 161, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "Patient 180 was evaluated for unclear or mumbled speech. The patient also presented with a pediatric-onset disorder and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 181, who has a history of an abnormal thalamic MRI signal. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 182, who has a history of slurred, consistent with dysarthria. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 89, "label": "HPO_TERM"}, {"start": 117, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 183, who has a history of slurred, consistent with dysarthria. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 89, "label": "HPO_TERM"}, {"start": 117, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient 184 was evaluated for an adult onset. The patient also presented with an elevated hepatic transaminase concentration and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 185, who has a history of an increased lactate level. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 186, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed a seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 102, "label": "HPO_TERM"}, {"start": 130, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient 187 was evaluated for slurred, consistent with dysarthria. The patient also presented with hyperlactatemia and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 188 includes an elevated level of lactate in the blood and slurred, consistent with dysarthria. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 189 were an abnormal thalamic MRI signal and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 190 includes an elevated hepatic transaminase concentration and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "Patient 191 was evaluated for a pediatric-onset disorder. The patient also presented with signs of parkinsonism and bilateral ptosis. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 192 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 193, who has a history of an abnormal thalamic MRI signal. Examination also revealed signs of parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 194 includes drooping of both upper eyelids and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 195, who has a history of a seizure. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 65, "label": "HPO_TERM"}, {"start": 93, "end": 135, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 196 includes an adult onset and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 197, a patient with a pediatric-onset disorder. Further investigation showed an abnormal thalamic MRI signal and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 198 were an elevated hepatic transaminase concentration and an increased lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 199 were hyperlactatemia and an atypical thalamic signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 200 were a buildup of lactate in his bloodstream and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 201, who has a history of an abnormal thalamic MRI signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 151, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 202, a patient with a pediatric-onset disorder. Further investigation showed an abnormal thalamic MRI signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 203, who has a history of a seizure. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 65, "label": "HPO_TERM"}, {"start": 93, "end": 108, "label": "HPO_TERM"}, {"start": 163, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 204, who has a history of a buildup of lactate in his bloodstream. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient 205 was evaluated for poor articulation. The patient also presented with hyperlactatemia and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "Patient 206 was evaluated for a pediatric-onset disorder. The patient also presented with an elevated hepatic transaminase concentration and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient 207 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and an elevated hepatic transaminase concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 208, a patient with hyperlactatemia. Further investigation showed an elevated level of lactate in the blood and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 156, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "Patient 209 was evaluated for an increased lactate level. The patient also presented with an elevated level of lactate in the blood and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 210, a patient with bilateral ptosis. Further investigation showed an increased lactate level and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 156, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 211 includes an adult onset and an increased lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 212, a patient with a seizure disorder. Further investigation showed an abnormal thalamic MRI signal and poor articulation. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 151, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 213, a patient with a seizure disorder. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 128, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 214, who has a history of an abnormal thalamic MRI signal. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 215 includes an abnormal thalamic MRI signal and a seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 216, who has a history of an elevated hepatic transaminase concentration. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 152, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 217, who has a history of An elevated concentration of liver transaminases. Examination also revealed a history of recurrent seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 163, "label": "HPO_TERM"}, {"start": 218, "end": 222, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 218, a patient with a late-onset variant of the condition. Further investigation showed unclear or mumbled speech and hepatic enzyme levels were above the normal range. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 192, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 219 includes a pediatric-onset disorder and drooping of both upper eyelids. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X0, who has a history of myoclonic jerks. Examination also revealed a presentation in infancy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X1, who has a history of a diagnosis of ataxia. Examination also revealed generalized hypotonia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X2, who has a history of oropharyngeal dysphagia. Examination also revealed Mitochondrial proliferation leading to ragged-red fibers. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 78, "label": "HPO_TERM"}, {"start": 106, "end": 159, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "Patient X3 was evaluated for a diagnosis of ataxia. The patient also presented with abnormal EMG findings of a myopathic nature and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X4, a patient with myoclonic jerks. Further investigation showed a presentation in infancy and an inability to swallow properly. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X5, who has a history of an inability to swallow properly. Examination also revealed a lack of voluntary coordination of muscle movements. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 164, "label": "HPO_TERM"}, {"start": 219, "end": 223, "label": "GENE_VARIANT"}]}
{"text": "Patient X6 was evaluated for infantile hypotonia. The patient also presented with a complaint of dysphagia and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 143, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X7, who has a history of a diagnosis of ataxia. Examination also revealed decreased muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X8, a patient with a lack of voluntary coordination of muscle movements. Further investigation showed myoclonic activity and a diagnosis of external ophthalmoplegia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 188, "label": "HPO_TERM"}, {"start": 212, "end": 216, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X9, a patient with an infantile onset. Further investigation showed myoclonic seizures and a state of low muscle tone. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 141, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "Patient X10 was evaluated for difficulty swallowing. The patient also presented with an infantile onset and a sensation of food getting stuck. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient X11 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with infantile hypotonia and an infantile onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 67, "label": "HPO_TERM"}, {"start": 101, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X12, who has a history of myoclonic seizures. Examination also revealed problems with swallowing. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X13 were a sensation of food getting stuck and an infantile onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 98, "label": "HPO_TERM"}, {"start": 124, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X14, who has a history of an increased CSF protein concentration. Examination also revealed a diagnosis of external ophthalmoplegia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X15 includes an inability to swallow properly and a complaint of dysphagia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X16, who has a history of a diagnosis of sensory axonal neuropathy. Examination also revealed difficulty swallowing. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 96, "label": "HPO_TERM"}, {"start": 124, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X17, a patient with a lack of voluntary coordination of muscle movements. Further investigation showed an increased CSF protein concentration and problems with balance and coordination. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 99, "label": "HPO_TERM"}, {"start": 130, "end": 164, "label": "HPO_TERM"}, {"start": 169, "end": 203, "label": "HPO_TERM"}, {"start": 227, "end": 231, "label": "GENE_VARIANT"}]}
{"text": "Patient X18 was evaluated for a state of low muscle tone. The patient also presented with an increased CSF protein concentration and myoclonus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X19 includes a finding of ragged-red fibers and a reduction in muscle tone. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "Patient X20 was evaluated for myoclonus. The patient also presented with an infantile onset and EMG evidence of myopathy. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 90, "label": "HPO_TERM"}, {"start": 95, "end": 119, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X21, who has a history of myoclonic jerks. Examination also revealed an infantile onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 116, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X22 were unsteady gait and poor coordination and a complaint of dysphagia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X23, a patient with a condition affecting eye movement. Further investigation showed an increased CSF protein concentration and a diagnosis of ataxia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 81, "label": "HPO_TERM"}, {"start": 112, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 170, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X24 were myoclonus and an infantile onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 75, "label": "HPO_TERM"}, {"start": 101, "end": 105, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X25, a patient with myoclonic jerks. Further investigation showed hypotonia and difficulty swallowing. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 129, "label": "HPO_TERM"}, {"start": 153, "end": 157, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X26, a patient with myoclonic jerks. Further investigation showed a complaint of dysphagia and problems with balance and coordination. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 155, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient X27 was evaluated for a notable lack of muscle tone. The patient also presented with an infantile onset and a complaint of dysphagia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 58, "label": "HPO_TERM"}, {"start": 92, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X28, who has a history of myoclonic jerks. Examination also revealed a diagnosis of ataxia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient X29 was evaluated for an increased CSF protein concentration. The patient also presented with a state of low muscle tone and problems with swallowing. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X30, who has a history of difficulty swallowing. Examination also revealed a notable lack of muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X31 were a sensation of food getting stuck and a complaint of dysphagia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X32 includes a diagnosis of ataxia and an infantile onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X33 includes a diagnosis of sensory axonal neuropathy and myoclonic jerks. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X34 were a diagnosis of ataxia and EMG: myopathic abnormalities. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "Patient X35 was evaluated for a lack of voluntary coordination of muscle movements. The patient also presented with myoclonic jerks and a state of low muscle tone. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 81, "label": "HPO_TERM"}, {"start": 115, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X36 were an increased CSF protein concentration and a lack of voluntary coordination of muscle movements. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 134, "label": "HPO_TERM"}, {"start": 160, "end": 164, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X37, who has a history of myoclonic seizures. Examination also revealed ragged-red fibers on muscle biopsy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 135, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X38 includes a complaint of dysphagia and an infantile onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X39, a patient with a lack of voluntary coordination of muscle movements. Further investigation showed myoclonic jerks and problems with balance and coordination. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 99, "label": "HPO_TERM"}, {"start": 130, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 184, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X40 includes problems with swallowing and EMG results showing myopathic abnormalities. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X41, a patient with a presentation in infancy. Further investigation showed a diagnosis of external ophthalmoplegia and a diagnosis of ataxia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 165, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X42, who has a history of a diagnosis of external ophthalmoplegia. Examination also revealed problems with balance and coordination. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 93, "label": "HPO_TERM"}, {"start": 121, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X43, who has a history of an infantile onset. Examination also revealed a state of low muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X44 were a complaint of dysphagia and problems with balance and coordination. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X45, who has a history of an increased CSF protein concentration. Examination also revealed problems with swallowing. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X46 includes a complaint of dysphagia and myoclonic jerks. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "Patient X47 was evaluated for choking or coughing while eating. The patient also presented with a lack of voluntary coordination of muscle movements and a complaint of dysphagia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 172, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient X48 was evaluated for myoclonic seizures. The patient also presented with a diagnosis of external ophthalmoplegia and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X49 were problems with balance and coordination and a condition affecting eye movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X50 were myoclonic seizures and an increased CSF protein concentration. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X51, who has a history of an infantile onset. Examination also revealed a state of low muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "Patient X52 was evaluated for a lack of voluntary coordination of muscle movements. The patient also presented with an increased CSF protein concentration and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 81, "label": "HPO_TERM"}, {"start": 115, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X53 includes paralysis of the external eye muscles and ragged-red fibers on muscle biopsy. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 81, "label": "HPO_TERM"}, {"start": 86, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X54, who has a history of a diagnosis of external ophthalmoplegia. Examination also revealed myoclonic seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 93, "label": "HPO_TERM"}, {"start": 121, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X55 were a diagnosis of ataxia and an increased CSF protein concentration. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X56 includes a diagnosis of ataxia and a diagnosis of external ophthalmoplegia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X57, a patient with a diagnosis of external ophthalmoplegia. Further investigation showed myoclonic jerks and an infantile onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X58, who has a history of a state of low muscle tone. Examination also revealed myoclonic seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "Patient X59 was evaluated for ataxia. The patient also presented with a state of low muscle tone and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 36, "label": "HPO_TERM"}, {"start": 70, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient X60 was evaluated for myoclonic jerks. The patient also presented with problems with balance and coordination and a lack of voluntary coordination of muscle movements. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X61, a patient with myoclonic jerks. Further investigation showed a presentation in infancy and EMG: myopathic abnormalities. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 152, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient X62 was evaluated for an infantile onset. The patient also presented with a complaint of dysphagia and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient X63 was evaluated for an increased CSF protein concentration. The patient also presented with a lack of voluntary coordination of muscle movements and a complaint of dysphagia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 176, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X64 were myoclonic seizures and a state of low muscle tone. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "Patient X65 was evaluated for choking or coughing while eating. The patient also presented with a complaint of dysphagia and a state of low muscle tone. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X66, who has a history of problems with swallowing. Examination also revealed myoclonic jerks. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 78, "label": "HPO_TERM"}, {"start": 106, "end": 121, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient X67 was evaluated for incoordinated movements. The patient also presented with hypotonia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 115, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "Patient X68 was evaluated for hypotonia. The patient also presented with a presentation in infancy and a diagnosis of external ophthalmoplegia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X69 were a complaint of dysphagia and a lack of voluntary coordination of muscle movements. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "Patient X70 was evaluated for a state of low muscle tone. The patient also presented with problems with balance and coordination and a complaint of dysphagia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X71 includes difficulty swallowing and an infantile onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X72 includes an increased CSF protein concentration and myoclonic jerks. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X73, a patient with myoclonic jerks. Further investigation showed difficulty swallowing and a lack of voluntary coordination of muscle movements. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 171, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X74, a patient with a state of low muscle tone. Further investigation showed a presentation in infancy and a complaint of dysphagia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 155, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X75, a patient with a diagnosis of external ophthalmoplegia. Further investigation showed myoclonic seizures and a presentation in infancy. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient X76 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with a diagnosis of ataxia and EMG: myopathic abnormalities. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 67, "label": "HPO_TERM"}, {"start": 101, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 153, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X77, who has a history of myoclonic jerks. Examination also revealed an infantile onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 116, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X78 includes myoclonic jerks and an infantile onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X79 were myoclonic seizures and a lack of voluntary coordination of muscle movements. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X80 were a diagnosis of ataxia and problems with balance and coordination. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X81, who has a history of an increased CSF protein concentration. Examination also revealed ataxia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient X82 was evaluated for hypotonia. The patient also presented with an infantile onset and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 90, "label": "HPO_TERM"}, {"start": 95, "end": 110, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "Patient X83 was evaluated for choking or coughing while eating. The patient also presented with an increased CSF protein concentration and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X84 includes a lack of voluntary coordination of muscle movements and a presentation in infancy. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 127, "label": "HPO_TERM"}, {"start": 153, "end": 157, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X85 were an infantile onset and a condition affecting eye movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X86 includes myoclonic seizures and a lack of voluntary coordination of muscle movements. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X87 were a presentation in infancy and EMG: myopathic abnormalities. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X88 includes myoclonic seizures and myoclonic jerks. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X89, a patient with a state of low muscle tone. Further investigation showed hypotonia and myoclonic jerks. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 132, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X90 were a condition affecting eye movement and myoclonic jerks. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X91, a patient with myoclonic jerks. Further investigation showed a presentation in infancy and a condition affecting eye movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 157, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X92, a patient with myoclonic jerks. Further investigation showed difficulty swallowing and an infantile onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 137, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X93, who has a history of myoclonic seizures. Examination also revealed EMG: myopathic abnormalities. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X94 includes myoclonic jerks and incoordinated movements. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X95, who has a history of a diagnosis of ataxia. Examination also revealed problems with swallowing. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X96, who has a history of a presentation in infancy. Examination also revealed a diagnosis of ataxia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "Patient X97 was evaluated for a complaint of dysphagia. The patient also presented with myoclonic jerks and an infantile onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 101, "label": "HPO_TERM"}, {"start": 106, "end": 123, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X98, a patient with myoclonic jerks. Further investigation showed a diagnosis of external ophthalmoplegia and myoclonic seizures. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X99 were problems with balance and coordination and a condition affecting eye movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X100 includes ataxia and a presentation in infancy. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "Patient X101 was evaluated for myoclonic jerks. The patient also presented with problems with swallowing and a diagnosis of external ophthalmoplegia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "Patient X102 was evaluated for difficulty swallowing. The patient also presented with problems with balance and coordination and an increased CSF protein concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient X103 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with a complaint of dysphagia and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 163, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X104, who has a history of an increased CSF protein concentration. Examination also revealed an infantile onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 136, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X105 includes a lack of voluntary coordination of muscle movements and a complaint of dysphagia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "Patient X106 was evaluated for a condition affecting eye movement. The patient also presented with a state of low muscle tone and problems with balance and coordination. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 161, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "Patient X107 was evaluated for a lack of voluntary coordination of muscle movements. The patient also presented with a complaint of dysphagia and ataxia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 82, "label": "HPO_TERM"}, {"start": 116, "end": 138, "label": "HPO_TERM"}, {"start": 143, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X108 includes myoclonic jerks and hypotonia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 76, "label": "HPO_TERM"}, {"start": 102, "end": 106, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X109, who has a history of myoclonic seizures. Examination also revealed a complaint of dysphagia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X110 were myoclonic jerks and a state of low muscle tone. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X111, who has a history of myoclonic seizures. Examination also revealed incoordinated movements. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X112, who has a history of an increased CSF protein concentration. Examination also revealed a state of low muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X113 were problems with swallowing and a diagnosis of external ophthalmoplegia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "Patient X114 was evaluated for difficulty swallowing. The patient also presented with hypotonia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 115, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X115, a patient with a complaint of dysphagia. Further investigation showed hypotonia and myoclonic seizures. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 133, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X116 were problems with balance and coordination and a condition affecting eye movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient X117 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with myoclonic seizures and an increased CSF protein concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient X118 was evaluated for an infantile onset. The patient also presented with a complaint of dysphagia and a state of low muscle tone. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X119, a patient with a state of low muscle tone. Further investigation showed difficulty swallowing and an infantile onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 147, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "Patient X120 was evaluated for myoclonic seizures. The patient also presented with a diagnosis of external ophthalmoplegia and an infantile onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X121 includes a diagnosis of sensory axonal neuropathy and a state of low muscle tone. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 87, "label": "HPO_TERM"}, {"start": 92, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "Patient X122 was evaluated for a state of low muscle tone. The patient also presented with a diagnosis of external ophthalmoplegia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X123, who has a history of a state of low muscle tone. Examination also revealed a diagnosis of sensory axonal neuropathy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X124 includes myoclonic jerks and a diagnosis of ataxia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient X125 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with problems with swallowing and a presentation in infancy. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 154, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "Patient X126 was evaluated for a condition affecting eye movement. The patient also presented with an increased CSF protein concentration and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 152, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X127 were myoclonic seizures and an increased CSF protein concentration. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient X128 was evaluated for a state of low muscle tone. The patient also presented with an infantile onset and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X129 includes a state of low muscle tone and problems with balance and coordination. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "Patient X130 was evaluated for difficulty swallowing. The patient also presented with a presentation in infancy and a diagnosis of external ophthalmoplegia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 153, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X131 includes a condition affecting eye movement and a diagnosis of ataxia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X132 were problems with swallowing and a lack of voluntary coordination of muscle movements. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient X133 was evaluated for an increased CSF protein concentration. The patient also presented with a diagnosis of sensory axonal neuropathy and a diagnosis of ataxia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 65, "label": "HPO_TERM"}, {"start": 99, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 163, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X134, a patient with myoclonic jerks. Further investigation showed a presentation in infancy and a diagnosis of external ophthalmoplegia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 162, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X135, who has a history of myoclonic seizures. Examination also revealed a diagnosis of sensory axonal neuropathy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X136 includes a state of low muscle tone and a diagnosis of sensory axonal neuropathy. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X137 includes difficulty swallowing and hypotonia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 82, "label": "HPO_TERM"}, {"start": 108, "end": 112, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X138 were a diagnosis of ataxia and hypotonia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 78, "label": "HPO_TERM"}, {"start": 104, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X139 includes a diagnosis of external ophthalmoplegia and ataxia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X140, who has a history of a diagnosis of external ophthalmoplegia. Examination also revealed a diagnosis of ataxia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 141, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "Patient X141 was evaluated for myoclonic seizures. The patient also presented with a diagnosis of external ophthalmoplegia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient X142 was evaluated for a state of low muscle tone. The patient also presented with myoclonic jerks and a diagnosis of external ophthalmoplegia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X143 includes problems with balance and coordination and a diagnosis of ataxia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 81, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X144 were myoclonic jerks and a diagnosis of external ophthalmoplegia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X145, who has a history of problems with balance and coordination. Examination also revealed myoclonic seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 136, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X146 were myoclonic seizures and EMG: myopathic abnormalities. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X147, who has a history of myoclonic jerks. Examination also revealed EMG: myopathic abnormalities. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 72, "label": "HPO_TERM"}, {"start": 100, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X148, who has a history of incoordinated movements. Examination also revealed a diagnosis of external ophthalmoplegia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 144, "label": "HPO_TERM"}, {"start": 199, "end": 203, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X149, who has a history of hypotonia. Examination also revealed an infantile onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 66, "label": "HPO_TERM"}, {"start": 94, "end": 111, "label": "HPO_TERM"}, {"start": 166, "end": 170, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X150 were a diagnosis of ataxia and an increased CSF protein concentration. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X151 includes ataxia and a diagnosis of external ophthalmoplegia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X152 includes a diagnosis of ataxia and hypotonia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X153 includes an infantile onset and EMG results showing myopathic abnormalities. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X154, a patient with a state of low muscle tone. Further investigation showed a presentation in infancy and EMG: myopathic abnormalities. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 162, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X155 were incoordinated movements and a diagnosis of external ophthalmoplegia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X156, a patient with a diagnosis of external ophthalmoplegia. Further investigation showed a state of low muscle tone and problems with swallowing. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 168, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X157, a patient with a state of low muscle tone. Further investigation showed a complaint of dysphagia and an increased CSF protein concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 165, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient X158 was evaluated for myoclonic jerks. The patient also presented with a diagnosis of sensory axonal neuropathy and myoclonus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 134, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X159 includes myoclonic seizures and a lack of voluntary coordination of muscle movements. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X160 were an increased CSF protein concentration and problems with swallowing. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "Patient X161 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with myoclonic jerks and a state of low muscle tone. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X162 includes a presentation in infancy and a diagnosis of ataxia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X163 includes difficulty swallowing and myoclonic jerks. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "Patient X164 was evaluated for difficulty swallowing. The patient also presented with a diagnosis of external ophthalmoplegia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 143, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient X165 was evaluated for myoclonic seizures. The patient also presented with myoclonus and a diagnosis of sensory axonal neuropathy. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X166, a patient with problems with balance and coordination. Further investigation showed a complaint of dysphagia and an increased CSF protein concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 83, "label": "HPO_TERM"}, {"start": 114, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 175, "label": "HPO_TERM"}, {"start": 199, "end": 203, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X167, who has a history of incoordinated movements. Examination also revealed myoclonic jerks. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X168 were myoclonic jerks and a diagnosis of ataxia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "Patient X169 was evaluated for ataxia. The patient also presented with hypotonia and myoclonic jerks. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 100, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "Patient X170 was evaluated for a diagnosis of ataxia. The patient also presented with a diagnosis of external ophthalmoplegia and a lack of voluntary coordination of muscle movements. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X171 were a presentation in infancy and a diagnosis of ataxia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X172, a patient with ataxia. Further investigation showed a diagnosis of external ophthalmoplegia and a complaint of dysphagia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 55, "label": "HPO_TERM"}, {"start": 86, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 150, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X173, who has a history of myoclonic jerks. Examination also revealed a diagnosis of external ophthalmoplegia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 72, "label": "HPO_TERM"}, {"start": 100, "end": 137, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "Patient X174 was evaluated for ataxia. The patient also presented with myoclonus and an infantile onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 102, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X175, who has a history of hypotonia. Examination also revealed a presentation in infancy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 66, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X176 were myoclonic seizures and a lack of voluntary coordination of muscle movements. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 118, "label": "HPO_TERM"}, {"start": 144, "end": 148, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X177, a patient with hypotonia. Further investigation showed a lack of voluntary coordination of muscle movements and a presentation in infancy. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 58, "label": "HPO_TERM"}, {"start": 89, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 170, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient X178 was evaluated for myoclonic jerks. The patient also presented with a diagnosis of external ophthalmoplegia and a complaint of dysphagia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X179 were hypotonia and problems with swallowing. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 54, "label": "HPO_TERM"}, {"start": 59, "end": 81, "label": "HPO_TERM"}, {"start": 107, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X180 includes an infantile onset and a diagnosis of sensory axonal neuropathy. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "Patient X181 was evaluated for a state of low muscle tone. The patient also presented with problems with swallowing and ataxia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 122, "label": "HPO_TERM"}, {"start": 153, "end": 157, "label": "GENE_VARIANT"}]}
{"text": "Patient X182 was evaluated for an increased CSF protein concentration. The patient also presented with problems with balance and coordination and a diagnosis of sensory axonal neuropathy. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 65, "label": "HPO_TERM"}, {"start": 99, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 178, "label": "HPO_TERM"}, {"start": 209, "end": 213, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X183, who has a history of a diagnosis of external ophthalmoplegia. Examination also revealed incoordinated movements. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 144, "label": "HPO_TERM"}, {"start": 199, "end": 203, "label": "GENE_VARIANT"}]}
{"text": "Patient X184 was evaluated for a diagnosis of external ophthalmoplegia. The patient also presented with a diagnosis of ataxia and problems with swallowing. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient X185 was evaluated for myoclonic jerks. The patient also presented with hypotonia and myoclonus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 103, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X186, who has a history of myoclonic seizures. Examination also revealed a state of low muscle tone. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 126, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X187 were a complaint of dysphagia and problems with swallowing. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X188, who has a history of a condition affecting eye movement. Examination also revealed a presentation in infancy. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X189 includes myoclonic jerks and incoordinated movements. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X190, a patient with hypotonia. Further investigation showed a diagnosis of sensory axonal neuropathy and myoclonus. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 58, "label": "HPO_TERM"}, {"start": 89, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 143, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient X191, who has a history of a diagnosis of external ophthalmoplegia. Examination also revealed incoordinated movements. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 144, "label": "HPO_TERM"}, {"start": 199, "end": 203, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient X192, a patient with problems with swallowing. Further investigation showed a presentation in infancy and myoclonic jerks. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 147, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "Patient X193 was evaluated for a state of low muscle tone. The patient also presented with myoclonic seizures and incoordinated movements. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X194 were a presentation in infancy and a diagnosis of ataxia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X195 were myoclonic seizures and an increased CSF protein concentration. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient X196 includes a raised CSF protein level and swallowing difficulties. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient X197 were external ophthalmoplegia and the patient was hypotonic. Analysis of the POLG gene was performed.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 97, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "Patient X198 was evaluated for a history of myoclonus. The patient also presented with swallowing difficulties and classic ragged-red fibers. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "Patient X199 was evaluated for an increased CSF protein concentration. The patient also presented with a lack of voluntary coordination of muscle movements and problems with swallowing. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 65, "label": "HPO_TERM"}, {"start": 99, "end": 150, "label": "HPO_TERM"}, {"start": 155, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z0, a patient with abnormal findings on diffusion-weighted imaging. Further investigation showed a progressive slowness of movement and a reduction in complex IV activity. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 94, "label": "HPO_TERM"}, {"start": 125, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 198, "label": "HPO_TERM"}, {"start": 223, "end": 227, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z1, who has a history of elevated ALT enzymatic activity. Examination also revealed a partial deficiency of complex I. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "Patient Z2 was evaluated for impaired function of mitochondrial complex I. The patient also presented with impaired function of mitochondrial complex IV and reduced mitochondrial DNA content in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 196, "label": "HPO_TERM"}, {"start": 227, "end": 231, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z3, a patient with a defect in mitochondrial complex I. Further investigation showed abnormal findings on diffusion-weighted imaging and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 81, "label": "HPO_TERM"}, {"start": 112, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 183, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z4 were a severe reduction of mtDNA in muscle and abnormal morphology of the cerebral cortex. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 128, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z5 were a reduction in complex I activity and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Z6 was evaluated for elevated alanine aminotransferase. The patient also presented with abnormal DWI signal on brain MRI and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 166, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z7 were slowness of movement and a defect in mitochondrial complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Z8 was evaluated for slowness of movement. The patient also presented with low complex I enzymatic activity and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 48, "label": "HPO_TERM"}, {"start": 82, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z9, a patient with a congenital malformation of the cerebral cortex. Further investigation showed a rise in AST concentration and a partial deficiency of complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 153, "label": "HPO_TERM"}, {"start": 158, "end": 191, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z10 includes an increase in the serum level of alanine aminotransferase and a severe reduction of mtDNA in muscle. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 153, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z11 were a defect in mitochondrial complex I and areas of restricted diffusion on brain DWI. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 126, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z12 includes a severe reduction of mtDNA in muscle and a defect in mitochondrial complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "Patient Z13 was evaluated for slowness of movement. The patient also presented with bradykinesia and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient Z14 was evaluated for multiple deletions in the mitochondrial DNA. The patient also presented with an accumulation of multiple mtDNA deletions and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 185, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z15 were a decrease in mitochondrial DNA in the muscles and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z16 includes low levels of mitochondrial DNA in muscle and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Z17 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with abnormal DWI signal on brain MRI and a partial deficiency of complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 175, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z18, who has a history of deficient cytochrome c oxidase activity. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient Z19 was evaluated for an increase in the serum level of alanine aminotransferase. The patient also presented with areas of restricted diffusion on brain DWI and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 89, "label": "HPO_TERM"}, {"start": 123, "end": 166, "label": "HPO_TERM"}, {"start": 171, "end": 197, "label": "HPO_TERM"}, {"start": 228, "end": 232, "label": "GENE_VARIANT"}]}
{"text": "Patient Z20 was evaluated for elevated alanine aminotransferase. The patient also presented with bradykinesia and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient Z21 was evaluated for a rise in AST concentration. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z22, a patient with a reduction in complex IV activity. Further investigation showed slowness of movement and an increase in CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z23 includes high levels of alanine aminotransferase and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z24 includes a defect in mitochondrial complex I and a progressive slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z25, who has a history of high levels of aspartate aminotransferase. Examination also revealed a low copy number of mtDNA in muscle tissue. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z26 includes a low copy number of mtDNA in muscle tissue and low complex I enzymatic activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z27 includes an accumulation of multiple mtDNA deletions and a partial deficiency of complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 87, "label": "HPO_TERM"}, {"start": 92, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "Patient Z28 was evaluated for slowness of movement. The patient also presented with a quantitative defect of mitochondrial DNA in muscle and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z29, who has a history of high ALT levels. Examination also revealed a rise in AST concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "Patient Z30 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a rise in AST concentration and areas of restricted diffusion on brain DWI. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "Patient Z31 was evaluated for a defect in mitochondrial complex I. The patient also presented with a partial deficiency of complex I and an accumulation of multiple mtDNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 64, "label": "HPO_TERM"}, {"start": 98, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z32 were a quantitative defect of mitochondrial DNA in muscle and a progressive slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 133, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z33 were a severe reduction of mtDNA in muscle and an increase in CSF lactate. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z34 were a partial deficiency of complex I and a reduction in complex I activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "Patient Z35 was evaluated for a general slowing of physical movements. The patient also presented with a reduction in complex I activity and multiple deletions in the mitochondrial DNA. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 181, "label": "HPO_TERM"}, {"start": 212, "end": 216, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z36, a patient with bradykinesia. Further investigation showed a reduction in complex I activity and a decrease in mitochondrial DNA in the muscles. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 176, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z37, a patient with elevated aspartate aminotransferase. Further investigation showed a quantitative defect of mitochondrial DNA in muscle and elevated lactate in CSF. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 83, "label": "HPO_TERM"}, {"start": 114, "end": 164, "label": "HPO_TERM"}, {"start": 169, "end": 190, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z38, a patient with a severe reduction of mtDNA in muscle. Further investigation showed an abnormal thalamic MRI signal and an elevated circulating aspartate aminotransferase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 211, "label": "HPO_TERM"}, {"start": 235, "end": 239, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z39, who has a history of an abnormal thalamic MRI signal. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Z40 was evaluated for slowness of movement. The patient also presented with areas of restricted diffusion on brain DWI and an increase in CSF lactate. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 153, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z41 includes a congenital malformation of the cerebral cortex and high levels of aspartate aminotransferase. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 139, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z42, a patient with abnormally high ALT levels. Further investigation showed complex I deficiency and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "Patient Z43 was evaluated for multiple deletions in the mitochondrial DNA. The patient also presented with a reduction in complex IV activity and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 183, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z44 includes a defect in mitochondrial complex I and a reduction in complex I activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 118, "label": "HPO_TERM"}, {"start": 144, "end": 148, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z45 were a rise in AST concentration and a severe reduction of mtDNA in muscle. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z46, a patient with a history of reduced mitochondrial DNA content in muscle. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient Z47 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with slowness of movement and abnormal cortical architecture. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z48 were a partial deficiency of complex I and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z49 were an abnormal thalamic MRI signal and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Z50 was evaluated for abnormal findings on diffusion-weighted imaging. The patient also presented with bradykinesia and high AST levels. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 77, "label": "HPO_TERM"}, {"start": 111, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z51, who has a history of slowness of movement. Examination also revealed areas of restricted diffusion on brain DWI. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z52, a patient with slowness of movement. Further investigation showed a low copy number of mtDNA in muscle tissue and a defect in mitochondrial complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 179, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient Z53 was evaluated for slowness of movement. The patient also presented with a congenital malformation of the cerebral cortex and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z54 were an accumulation of multiple mtDNA deletions and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z55, a patient with high levels of aspartate aminotransferase. Further investigation showed bradykinesia and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 160, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient Z56 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with an elevated circulating aspartate aminotransferase concentration and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 165, "label": "HPO_TERM"}, {"start": 170, "end": 189, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z57 were a structural malformation of the brain's outer layer and high ALT levels. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "Patient Z58 was evaluated for high AST levels. The patient also presented with an accumulation of multiple mtDNA deletions and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z59 were an increase in the serum level of aspartate aminotransferase and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z60, a patient with an accumulation of multiple mtDNA deletions. Further investigation showed high levels of alanine aminotransferase and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 89, "label": "HPO_TERM"}, {"start": 120, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 189, "label": "HPO_TERM"}, {"start": 213, "end": 217, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z61 includes multiple deletions in the mitochondrial DNA and a severe reduction of mtDNA in muscle. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 87, "label": "HPO_TERM"}, {"start": 92, "end": 131, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Z62 was evaluated for an accumulation of multiple mtDNA deletions. The patient also presented with an elevated circulating aspartate aminotransferase concentration and a quantitative defect of mitochondrial DNA in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 71, "label": "HPO_TERM"}, {"start": 105, "end": 164, "label": "HPO_TERM"}, {"start": 169, "end": 219, "label": "HPO_TERM"}, {"start": 250, "end": 254, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z63 includes a reduction in complex I activity and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z64, a patient with a partial deficiency of complex I. Further investigation showed a reduction in complex IV activity and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 81, "label": "HPO_TERM"}, {"start": 112, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 170, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient Z65 was evaluated for an increase in CSF lactate. The patient also presented with complex I deficiency and multiple mitochondrial DNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient Z66 was evaluated for a congenital malformation of the cerebral cortex. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 79, "label": "HPO_TERM"}, {"start": 113, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 185, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z67, a patient with elevated ALT enzymatic activity. Further investigation showed a partial deficiency of complex I and deficient cytochrome c oxidase activity. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 79, "label": "HPO_TERM"}, {"start": 110, "end": 143, "label": "HPO_TERM"}, {"start": 148, "end": 186, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z68 were high ALT levels and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z69 were a low copy number of mtDNA in muscle tissue and low complex I enzymatic activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z70 were an abnormal thalamic MRI signal and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z71, a patient with complex I deficiency. Further investigation showed a partial deficiency of complex I and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z72, who has a history of slowness of movement. Examination also revealed low complex I enzymatic activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z73 includes a reduction in complex I activity and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z74 were an elevated CSF lactate level and cytochrome c oxidase deficiency. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z75 were an abnormal thalamic MRI signal and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z76 includes increased ALT in the blood and high ALT levels. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z77 includes the presence of multiple mtDNA deletions and a reduction in complex IV activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z78, who has a history of an abnormal thalamic MRI signal. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Z79 was evaluated for reduced mitochondrial DNA content in muscle. The patient also presented with areas of restricted diffusion on brain DWI and a rise in AST concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 149, "label": "HPO_TERM"}, {"start": 154, "end": 180, "label": "HPO_TERM"}, {"start": 211, "end": 215, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z80 were a decrease in mitochondrial DNA in the muscles and a defect in mitochondrial complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z81, who has a history of an elevated CSF lactate level. Examination also revealed difficulty initiating movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 137, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z82 were a progressive slowness of movement and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z83, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed slowness of movement. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 103, "label": "HPO_TERM"}, {"start": 131, "end": 150, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z84, a patient with a defect in mitochondrial complex I. Further investigation showed slowness of movement and an accumulation of multiple mtDNA deletions. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 178, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z85, a patient with a quantitative defect of mitochondrial DNA in muscle. Further investigation showed a rise in AST concentration and a low copy number of mtDNA in muscle tissue. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 155, "label": "HPO_TERM"}, {"start": 160, "end": 202, "label": "HPO_TERM"}, {"start": 226, "end": 230, "label": "GENE_VARIANT"}]}
{"text": "Patient Z86 was evaluated for an increase in CSF lactate. The patient also presented with complex I deficiency and a severe reduction of mtDNA in muscle. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z87, a patient with a progressive slowness of movement. Further investigation showed complex I deficiency and an increase in CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z88 includes the occurrence of multiple mtDNA deletions and a defect in mitochondrial complex I. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z89 were an elevated CSF lactate level and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z90 were an elevated CSF lactate level and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient Z91 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an elevated circulating aspartate aminotransferase concentration and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 162, "label": "HPO_TERM"}, {"start": 167, "end": 186, "label": "HPO_TERM"}, {"start": 217, "end": 221, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z92, a patient with a reduction in complex IV activity. Further investigation showed a progressive slowness of movement and abnormal cortical architecture. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 180, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z93 were a rise in AST concentration and a low copy number of mtDNA in muscle tissue. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z94 includes high AST levels and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z95, who has a history of slowness of movement. Examination also revealed cytochrome c oxidase deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 75, "label": "HPO_TERM"}, {"start": 103, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z96, a patient with slowness of movement. Further investigation showed deficient cytochrome c oxidase activity and an accumulation of multiple mtDNA deletions. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 182, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "Patient Z97 was evaluated for increased CSF lactate. The patient also presented with a progressive slowness of movement and bradykinesia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z98, a patient with an elevated CSF lactate level. Further investigation showed a progressive slowness of movement and complex I deficiency. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 138, "label": "HPO_TERM"}, {"start": 143, "end": 162, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z99, a patient with bradykinesia. Further investigation showed a reduction in complex IV activity and high levels of alanine aminotransferase. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 169, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z100 was evaluated for slowness of movement. The patient also presented with a severe reduction of mtDNA in muscle and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z101 were high levels of alanine aminotransferase and bradykinesia. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z102 were elevated ALT enzymatic activity and a decrease in mitochondrial DNA in the muscles. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 128, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z103, who has a history of an elevated CSF lactate level. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z104, who has a history of a reduction in complex I activity. Examination also revealed abnormal cortical architecture. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z105, a patient with reduced mitochondrial DNA content in muscle. Further investigation showed a partial deficiency of complex I and high AST levels. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 155, "label": "HPO_TERM"}, {"start": 160, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient Z106 was evaluated for abnormally high AST levels. The patient also presented with a defect in mitochondrial complex I and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z107 were elevated aspartate aminotransferase and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z108, who has a history of high levels of alanine aminotransferase. Examination also revealed a decrease in mitochondrial DNA in the muscles. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 96, "label": "HPO_TERM"}, {"start": 124, "end": 171, "label": "HPO_TERM"}, {"start": 226, "end": 230, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z109 includes a decrease in mitochondrial DNA in the muscles and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 111, "label": "HPO_TERM"}, {"start": 137, "end": 141, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z110 were elevated alanine aminotransferase and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z111 were abnormal findings on diffusion-weighted imaging and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z112, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed elevated lactate in CSF. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 153, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z113, who has a history of an elevated CSF lactate level. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z114 were abnormal findings on diffusion-weighted imaging and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z115, who has a history of a reduction in complex IV activity. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Z116 was evaluated for abnormally high AST levels. The patient also presented with multiple mitochondrial DNA deletions and complex I deficiency. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z117, a patient with slowness of movement. Further investigation showed multiple mitochondrial DNA deletions and high AST levels. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z118 includes high levels of alanine aminotransferase and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z119, a patient with slowness of movement. Further investigation showed a low copy number of mtDNA in muscle tissue and a defect in mitochondrial complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 180, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "Patient Z120 was evaluated for high levels of alanine aminotransferase. The patient also presented with areas of restricted diffusion on brain DWI and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 186, "label": "HPO_TERM"}, {"start": 217, "end": 221, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z121, a patient with abnormal findings on diffusion-weighted imaging. Further investigation showed slowness of movement and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 176, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z122 were complex I deficiency and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z123, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed a low copy number of mtDNA in muscle tissue. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 174, "label": "HPO_TERM"}, {"start": 229, "end": 233, "label": "GENE_VARIANT"}]}
{"text": "Patient Z124 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with a defect in mitochondrial complex I and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 173, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z125 were difficulty initiating movement and a reduction in complex IV activity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z126 includes an elevated CSF lactate level and cytochrome c oxidase deficiency. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z127, a patient with abnormal cortical architecture. Further investigation showed a reduction in complex IV activity and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 142, "label": "HPO_TERM"}, {"start": 147, "end": 172, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "Patient Z128 was evaluated for slowness of movement. The patient also presented with a reduction in complex IV activity and abnormal findings on diffusion-weighted imaging. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 170, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z129 includes abnormally high AST levels and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z130, a patient with a congenital malformation of the cerebral cortex. Further investigation showed deficient cytochrome c oxidase activity and an elevated CSF lactate level. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 167, "label": "HPO_TERM"}, {"start": 172, "end": 197, "label": "HPO_TERM"}, {"start": 221, "end": 225, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z131, a patient with high levels of aspartate aminotransferase. Further investigation showed a defect in mitochondrial complex I and increased CSF lactate. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 153, "label": "HPO_TERM"}, {"start": 158, "end": 179, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z132, who has a history of slowness of movement. Examination also revealed a reduction in complex IV activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z133 was evaluated for an elevated CSF lactate level. The patient also presented with a partial deficiency of complex I and a defect in mitochondrial complex I. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z134 was evaluated for high levels of alanine aminotransferase. The patient also presented with abnormal cortical architecture and elevated lactate in CSF. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z135, a patient with an increase in CSF lactate. Further investigation showed an elevated circulating aspartate aminotransferase concentration and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 161, "label": "HPO_TERM"}, {"start": 166, "end": 185, "label": "HPO_TERM"}, {"start": 209, "end": 213, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z136 were a partial deficiency of complex I and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z137, who has a history of an abnormal thalamic MRI signal. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z138 were abnormally high ALT levels and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z139 includes an elevated CSF lactate level and an elevated circulating aspartate aminotransferase concentration. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 136, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z140 includes an elevated circulating aspartate aminotransferase concentration and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z141 were a reduction in complex IV activity and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z142, a patient with a reduction in complex I activity. Further investigation showed a decrease in mitochondrial DNA in the muscles and slowness of movement. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 160, "label": "HPO_TERM"}, {"start": 165, "end": 184, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z143, who has a history of slowness of movement. Examination also revealed elevated lactate in CSF. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z144, who has a history of an elevated CSF lactate level. Examination also revealed bradykinesia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z145 were an elevated CSF lactate level and a decrease in mitochondrial DNA in the muscles. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "Patient Z146 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an elevated CSF lactate level and high levels of alanine aminotransferase. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 173, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z147 were slowness of movement and multiple mitochondrial DNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z148 were abnormal cortical architecture and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z149, a patient with a severe reduction of mtDNA in muscle. Further investigation showed multiple mitochondrial DNA deletions and high levels of alanine aminotransferase. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 154, "label": "HPO_TERM"}, {"start": 159, "end": 198, "label": "HPO_TERM"}, {"start": 222, "end": 226, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z150 includes complex I deficiency and multiple mitochondrial DNA deletions. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Z151 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with an accumulation of multiple mtDNA deletions and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z152, who has a history of slowness of movement. Examination also revealed abnormally high ALT levels. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z153 were a reduction in complex IV activity and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "Patient Z154 was evaluated for a low copy number of mtDNA in muscle tissue. The patient also presented with slowness of movement and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 73, "label": "HPO_TERM"}, {"start": 107, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 156, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z155 were increased ALT in the blood and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z156 includes reduced mitochondrial DNA content in muscle and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z157 were abnormally high AST levels and an elevated CSF lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Z158 was evaluated for slowness of movement. The patient also presented with a partial deficiency of complex I and a progressive slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 156, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z159 includes a quantitative defect of mitochondrial DNA in muscle and bradykinesia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z160, a patient with a reduction in complex I activity. Further investigation showed a severe reduction of mtDNA in muscle and a quantitative defect of mitochondrial DNA in muscle. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 207, "label": "HPO_TERM"}, {"start": 231, "end": 235, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z161, who has a history of slowness of movement. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z162, a patient with slowness of movement. Further investigation showed abnormally high AST levels and a quantitative defect of mitochondrial DNA in muscle. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 178, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z163, who has a history of an elevated CSF lactate level. Examination also revealed multiple mitochondrial DNA deletions. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient Z164 was evaluated for increased CSF lactate. The patient also presented with abnormally high ALT levels and multiple mitochondrial DNA deletions. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z165, a patient with mtDNA depletion in muscle. Further investigation showed an increase in CSF lactate and areas of restricted diffusion on brain DWI. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z166, who has a history of deficient cytochrome c oxidase activity. Examination also revealed complex I deficiency. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z167, who has a history of complex I deficiency. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z168 were slowness of movement and abnormal cortical architecture. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z169, who has a history of a reduction in complex IV activity. Examination also revealed elevated ALT enzymatic activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 150, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z170 includes an increase in the serum level of aspartate aminotransferase and slowness of movement. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 130, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z171 were a partial deficiency of complex I and an accumulation of multiple mtDNA deletions. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z172 includes a defect in mitochondrial complex I and a reduction in complex IV activity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 81, "label": "HPO_TERM"}, {"start": 86, "end": 120, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z173 were bradykinesia and slowness of movement. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 81, "label": "HPO_TERM"}, {"start": 107, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "Patient Z174 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with abnormal cortical architecture and an elevated CSF lactate level. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient Z175 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with an elevated circulating aspartate aminotransferase concentration and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 159, "label": "HPO_TERM"}, {"start": 164, "end": 211, "label": "HPO_TERM"}, {"start": 242, "end": 246, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z176, a patient with a reduction in complex I activity. Further investigation showed a rise in AST concentration and a partial deficiency of complex I. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 177, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z177 includes a partial deficiency of complex I and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z178, who has a history of slowness of movement. Examination also revealed multiple mitochondrial DNA deletions. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z179 were a severe reduction of mtDNA in muscle and a partial deficiency of complex I. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z180 includes reduced mitochondrial DNA content in muscle and an elevated CSF lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 145, "end": 149, "label": "GENE_VARIANT"}]}
{"text": "Patient Z181 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a partial deficiency of complex I and bradykinesia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 154, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z182, who has a history of complex I deficiency. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient Z183 was evaluated for multiple mitochondrial DNA deletions. The patient also presented with abnormal cortical architecture and slowness of movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 66, "label": "HPO_TERM"}, {"start": 100, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 152, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z184 were abnormally high ALT levels and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient Z185 was evaluated for a severe reduction of mtDNA in muscle. The patient also presented with a partial deficiency of complex I and a reduction in complex IV activity. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 176, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "Patient Z186 was evaluated for abnormally high AST levels. The patient also presented with a partial deficiency of complex I and complex I deficiency. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Z187 was evaluated for increased CSF lactate. The patient also presented with slowness of movement and a decrease in mitochondrial DNA in the muscles. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z188, who has a history of deficient cytochrome c oxidase activity. Examination also revealed an elevated CSF lactate level. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Z189 includes bradykinesia and high AST levels. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 78, "label": "HPO_TERM"}, {"start": 104, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z190 were slowness of movement and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 98, "label": "HPO_TERM"}, {"start": 124, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z191, who has a history of slowness of movement. Examination also revealed high levels of alanine aminotransferase. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z192, who has a history of an accumulation of multiple mtDNA deletions. Examination also revealed a decrease in mitochondrial DNA in the muscles. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 173, "label": "HPO_TERM"}, {"start": 228, "end": 232, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z193, a patient with a partial deficiency of complex I. Further investigation showed a decrease in mitochondrial DNA in the muscles and a rise in AST concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 160, "label": "HPO_TERM"}, {"start": 165, "end": 191, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Z194 were a defect in mitochondrial complex I and cytochrome c oxidase deficiency. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z195, who has a history of a decrease in mitochondrial DNA in the muscles. Examination also revealed a reduction in complex I activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "Patient Z196 was evaluated for abnormally high AST levels. The patient also presented with increased CSF lactate and slowness in voluntary movement. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Z197, a patient with a reduction in complex I activity. Further investigation showed deficient cytochrome c oxidase activity and restricted diffusion on cerebral MRI. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 82, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 193, "label": "HPO_TERM"}, {"start": 218, "end": 222, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z198, who has a history of elevated aspartate aminotransferase. Examination also revealed elevated alanine aminotransferase. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 92, "label": "HPO_TERM"}, {"start": 120, "end": 153, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Z199, who has a history of complex I deficiency. Examination also revealed a reduction in complex I activity. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y0, who has a history of symptoms of anxiety. Examination also revealed a significant decrease in body weight. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y1, a patient with a face with diminished mimetic function. Further investigation showed bilateral tonic-clonic seizures and a significant decrease in body weight. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 148, "label": "HPO_TERM"}, {"start": 153, "end": 190, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y2, a patient with episodes of intense anxiety. Further investigation showed insufficient liver function and a decrease in body mass. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 156, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y3 were a focal-onset seizure and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "Patient Y4 was evaluated for anxiety. The patient also presented with a focal T2 hyperintense thalamic lesion and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 36, "label": "HPO_TERM"}, {"start": 70, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y5 were a history of anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y6, a patient with a diagnosis of an anxiety disorder. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 78, "label": "HPO_TERM"}, {"start": 109, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 158, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "Patient Y7 was evaluated for a rhythmic shaking movement. The patient also presented with a soft or quiet voice and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 152, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y8, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 93, "label": "HPO_TERM"}, {"start": 121, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y9 includes a history of significant weight loss and anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y10 was evaluated for a weak voice. The patient also presented with seizures originating in one area of the brain and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 42, "label": "HPO_TERM"}, {"start": 76, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y11 were a limitation of upgaze and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y12, a patient with a history of anxiety. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Y13 was evaluated for a partial seizure. The patient also presented with poverty of facial expression and a limitation of upgaze. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 134, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "Patient Y14 was evaluated for a soft or quiet voice. The patient also presented with a tremor and bilateral tonic-clonic seizures. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 90, "label": "HPO_TERM"}, {"start": 95, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y15, who has a history of a fine tremor. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 104, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y16, a patient with a focal-onset seizure. Further investigation showed a soft or quiet voice and seizures originating in one area of the brain. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y17, a patient with a rhythmic shaking movement. Further investigation showed a partial seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 75, "label": "HPO_TERM"}, {"start": 106, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y18 were difficulty looking upwards and seizures with a localized origin. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y19, a patient with a focal-onset seizure. Further investigation showed a focal bright signal on T2 MRI of the thalamus and a history of significant weight loss. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 143, "label": "HPO_TERM"}, {"start": 148, "end": 183, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y20 includes difficulty looking upwards and a partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y21 includes progressive loss of weight and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y22 were a tremor and seizures originating in one area of the brain. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 124, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y23 were a focal T2 hyperintense thalamic lesion and a soft or quiet voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y24, a patient with an unexplained drop in weight. Further investigation showed a weak voice and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 163, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y25 were bilateral tonic-clonic seizures and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y26, who has a history of a decrease in body mass. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 114, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y27 includes focal seizures and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 85, "label": "HPO_TERM"}, {"start": 111, "end": 115, "label": "GENE_VARIANT"}]}
{"text": "Patient Y28 was evaluated for a tremor. The patient also presented with seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 151, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y29, who has a history of hypophonia. Examination also revealed a focal T2 hyperintense thalamic lesion. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 66, "label": "HPO_TERM"}, {"start": 94, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Y30 was evaluated for a focal-onset seizure. The patient also presented with feelings of anxiety and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y31, a patient with a weak voice. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 140, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y32, who has a history of a very quiet speaking voice. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y33, who has a history of a very quiet speaking voice. Examination also revealed a history of anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y34 were focal seizures and progressive loss of weight. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y35, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 100, "label": "HPO_TERM"}, {"start": 128, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y36 includes impaired liver function and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y37, who has a history of anxiety. Examination also revealed a vertical gaze palsy affecting upgaze. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 63, "label": "HPO_TERM"}, {"start": 91, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y38 were anxiety and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Y39 was evaluated for an expressionless face. The patient also presented with a soft or quiet voice and a simple partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y40 were a rhythmic shaking movement and a tremor. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y41, a patient with a focal-onset seizure. Further investigation showed a vertical gaze palsy affecting upgaze and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 153, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y42, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed a partial seizure and a soft or quiet voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 157, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y43 were a tremor and an involuntary trembling or shaking. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y44 includes feelings of anxiety and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "Patient Y45 was evaluated for a resting tremor. The patient also presented with a diagnosis of focal-onset seizures and a decrease in body mass. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y46 includes a decrease in body mass and poor liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y47 includes anxiety and a simple partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y48, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y49 includes a tremor and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 70, "label": "HPO_TERM"}, {"start": 96, "end": 100, "label": "GENE_VARIANT"}]}
{"text": "Patient Y50 was evaluated for weight loss. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 128, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y51 were bilateral tonic-clonic seizures and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Y52 was evaluated for impaired liver function. The patient also presented with seizures with a localized origin and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "Patient Y53 was evaluated for seizures with a localized origin. The patient also presented with a focal T2 hyperintense thalamic lesion and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y54 were bilateral tonic-clonic seizures and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y55 was evaluated for a very quiet speaking voice. The patient also presented with a partial seizure and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "Patient Y56 was evaluated for a focal-onset seizure. The patient also presented with a focal T2 hyperintense thalamic lesion and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 134, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y57 includes difficulty projecting the voice and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 74, "label": "HPO_TERM"}, {"start": 79, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient Y58 was evaluated for a reduction in facial animation. The patient also presented with paralysis of upward gaze and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y59, who has a history of a very quiet speaking voice. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y60, a patient with a focal-onset seizure. Further investigation showed seizures with a localized origin and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 173, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient Y61 was evaluated for seizures with a localized origin. The patient also presented with a soft or quiet voice and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y62 includes a mask-like facial expression and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 74, "label": "HPO_TERM"}, {"start": 79, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient Y63 was evaluated for a focal-onset seizure. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y64 were anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y65 were a weak voice and a tremor. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 56, "label": "HPO_TERM"}, {"start": 61, "end": 68, "label": "HPO_TERM"}, {"start": 94, "end": 98, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y66, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed seizures originating in one area of the brain. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 164, "label": "HPO_TERM"}, {"start": 219, "end": 223, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y67, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y68 were a decrease in body mass and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y69 was evaluated for a weak voice. The patient also presented with a focal T2 hyperintense thalamic lesion and anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 42, "label": "HPO_TERM"}, {"start": 76, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Y70 was evaluated for a resting tremor. The patient also presented with feelings of anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y71, who has a history of a very quiet speaking voice. Examination also revealed seizures with a localized origin. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 141, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y72 includes a simple partial seizure and anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y73, a patient with impaired liver function. Further investigation showed a weak voice and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 139, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y74 were a focal T2 hyperintense thalamic lesion and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Y75 was evaluated for a history of significant weight loss. The patient also presented with a partial seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 65, "label": "HPO_TERM"}, {"start": 99, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y76 includes bilateral tonic-clonic seizures and a history of anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Y77 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a partial seizure and a decrease in body mass. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y78, who has a history of poor liver function. Examination also revealed seizures with a localized origin. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y79, a patient with a focal-onset seizure. Further investigation showed a focal T2 hyperintense thalamic lesion and anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 149, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y80, a patient with a tremor. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 55, "label": "HPO_TERM"}, {"start": 86, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 149, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient Y81 was evaluated for a focal-onset seizure. The patient also presented with a weak voice and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y82 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "Patient Y83 was evaluated for a soft or quiet voice. The patient also presented with a partial seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient Y84 was evaluated for a focal-onset seizure. The patient also presented with a focal T2 hyperintense thalamic lesion and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y85, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y86, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y87 were a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y88 was evaluated for a tremor. The patient also presented with seizures with a localized origin and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Y89 was evaluated for a tremor. The patient also presented with anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 127, "label": "HPO_TERM"}, {"start": 158, "end": 162, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y90 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "Patient Y91 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with feelings of anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 74, "label": "HPO_TERM"}, {"start": 108, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 176, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y92 includes poor liver function and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y93 was evaluated for bilateral tonic-clonic seizures. The patient also presented with seizures with a localized origin and a partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y94 includes a tremor and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 78, "label": "HPO_TERM"}, {"start": 104, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y95, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a tremor. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 134, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y96 includes a focal T2 hyperintense thalamic lesion and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Y97 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a partial seizure and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 167, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y98, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed seizures with a localized origin and anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 148, "label": "HPO_TERM"}, {"start": 153, "end": 160, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y99 includes a weak voice and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y100 were a soft or quiet voice and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "Patient Y101 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 183, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "Patient Y102 was evaluated for anxiety. The patient also presented with a partial seizure and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 112, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient Y103 was evaluated for bilateral grand mal seizures. The patient also presented with a focal T2 hyperintense thalamic lesion and decreased liver function. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y104, a patient with a focal bright signal on T2 MRI of the thalamus. Further investigation showed a weak voice and feelings of anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 160, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y105 were feelings of anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y106 were a very quiet speaking voice and anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 82, "label": "HPO_TERM"}, {"start": 108, "end": 112, "label": "GENE_VARIANT"}]}
{"text": "Patient Y107 was evaluated for a simple partial seizure. The patient also presented with a tremor and bilateral tonic-clonic seizures. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y108, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 136, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "Patient Y109 was evaluated for bilateral grand mal seizures. The patient also presented with a partial seizure and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y110 includes bilateral grand mal seizures and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y111 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y112 were a tremor and impaired liver function. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y113, a patient with poor liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Y114 was evaluated for a tremor. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y115, a patient with impaired liver function. Further investigation showed seizures with a localized origin and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 159, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y116, a patient with a tremor. Further investigation showed bilateral grand mal seizures and seizures originating in one area of the brain. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 56, "label": "HPO_TERM"}, {"start": 87, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 162, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y117 includes a focal T2 hyperintense thalamic lesion and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y118, who has a history of anxiety. Examination also revealed a history of significant weight loss. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y119 were a weak voice and seizures with a localized origin. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y120 were a soft or quiet voice and seizures originating in one area of the brain. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y121 includes a focal-onset seizure and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y122 were bilateral tonic-clonic seizures and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y123, a patient with seizures originating in one area of the brain. Further investigation showed a reduction in facial animation and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 169, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y124, a patient with a weak voice. Further investigation showed a reduction in facial animation and a partial seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 143, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y125, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed seizures originating in one area of the brain. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y126, a patient with bilateral tonic-clonic seizures. Further investigation showed a focal-onset seizure and a partial seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 80, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 152, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y127, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed a history of anxiety and a focal bright signal on T2 MRI of the thalamus. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 186, "label": "HPO_TERM"}, {"start": 211, "end": 215, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y128, who has a history of a decrease in body mass. Examination also revealed a reduction in facial animation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y129 were a focal bright signal on T2 MRI of the thalamus and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Y130 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a soft or quiet voice and seizures originating in one area of the brain. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y131, a patient with seizures originating in one area of the brain. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 147, "end": 185, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "Patient Y132 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a history of anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "Patient Y133 was evaluated for a soft or quiet voice. The patient also presented with a history of anxiety and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y134 includes a focal T2 hyperintense thalamic lesion and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y135, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 141, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "Patient Y136 was evaluated for poor liver function. The patient also presented with seizures with a localized origin and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y137, who has a history of a tremor. Examination also revealed a simple partial seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 114, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "Patient Y138 was evaluated for a partial seizure. The patient also presented with a history of anxiety and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 143, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient Y139 was evaluated for a tremor. The patient also presented with bilateral grand mal seizures and seizures originating in one area of the brain. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y140 were a partial seizure and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y141, who has a history of a soft or quiet voice. Examination also revealed a simple partial seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient Y142 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with a partial seizure and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 75, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient Y143 was evaluated for bilateral grand mal seizures. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a history of significant weight loss. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y144, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y145, who has a history of a weak voice. Examination also revealed a decrease in body mass. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 120, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y146 were a focal-onset seizure and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y147 includes a weak voice and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 71, "label": "HPO_TERM"}, {"start": 97, "end": 101, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y148, a patient with a weak voice. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 141, "label": "HPO_TERM"}, {"start": 166, "end": 170, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y149 were a focal bright signal on T2 MRI of the thalamus and a decrease in body mass. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y150, who has a history of a soft or quiet voice. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient Y151 was evaluated for a weak voice. The patient also presented with impaired liver function and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y152 includes a partial seizure and a soft or quiet voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y153 were a focal bright signal on T2 MRI of the thalamus and anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Y154 was evaluated for a resting tremor. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y155 includes a weak voice and seizures originating in one area of the brain. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Y156 was evaluated for poor liver function. The patient also presented with seizures with a localized origin and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y157, a patient with a weak voice. Further investigation showed a focal T2 hyperintense thalamic lesion and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y158 includes a focal-onset seizure and poor liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y159 were a simple partial seizure and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 91, "label": "HPO_TERM"}, {"start": 117, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y160 includes a focal T2 hyperintense thalamic lesion and a partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Y161 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with a partial seizure and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 75, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y162 were difficulty projecting the voice and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y163 were a history of anxiety and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y164 were a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y165 was evaluated for seizures with a localized origin. The patient also presented with a focal T2 hyperintense thalamic lesion and anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Y166 was evaluated for difficulty projecting the voice. The patient also presented with a focal-onset seizure and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y167, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a history of anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y168, a patient with difficulty projecting the voice. Further investigation showed a focal-onset seizure and a soft or quiet voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 152, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Y169 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y170, a patient with a focal-onset seizure. Further investigation showed a focal bright signal on T2 MRI of the thalamus and a tremor. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 156, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y171, a patient with a weak voice. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y172 were a tremor and poor liver function. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 75, "label": "HPO_TERM"}, {"start": 101, "end": 105, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y173 includes focal seizures and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y174, who has a history of a reduction in facial animation. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 87, "label": "HPO_TERM"}, {"start": 115, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "Patient Y175 was evaluated for a resting tremor. The patient also presented with a soft or quiet voice and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 155, "end": 159, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y176, a patient with a focal bright signal on T2 MRI of the thalamus. Further investigation showed a focal-onset seizure and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y177, who has a history of a focal-onset seizure. Examination also revealed a focal T2 hyperintense thalamic lesion. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y178 were seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "Patient Y179 was evaluated for a soft or quiet voice. The patient also presented with a partial seizure and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y180 were a decrease in body mass and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y181, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 135, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y182, who has a history of a focal-onset seizure. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y183, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal bright signal on T2 MRI of the thalamus. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 172, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "Patient Y184 was evaluated for anxiety. The patient also presented with a weak voice and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient Y185 was evaluated for seizures with a localized origin. The patient also presented with a partial seizure and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y186, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y187, who has a history of a soft or quiet voice. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y188 were seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y189 were anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "Patient Y190 was evaluated for a partial seizure. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y191, a patient with a weak voice. Further investigation showed a focal T2 hyperintense thalamic lesion and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y192 includes a focal T2 hyperintense thalamic lesion and impaired liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Y193 was evaluated for seizures originating in one area of the brain. The patient also presented with a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 73, "label": "HPO_TERM"}, {"start": 107, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 170, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y194 were a partial seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "Patient Y195 was evaluated for seizures with a localized origin. The patient also presented with a tremor and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y196, who has a history of reduced vocal volume. Examination also revealed unintentional weight loss. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 130, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y197 includes bilateral grand mal seizures and weight loss. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 91, "label": "HPO_TERM"}, {"start": 117, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y198, who has a history of reduced vocal volume. Examination also revealed a diagnosis of focal-onset seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y199 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "Patient V0 was evaluated for pallhypesthesia. The patient also presented with a decrease in tendon reflexes and unilateral motor seizure activity. Subsequent sequencing of c.1156C>T p.R386C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 145, "label": "HPO_TERM"}, {"start": 172, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V1, a patient with tendon reflexes were difficult to elicit. Further investigation showed impaired coordination during walking and a kinetic tremor. A known variant in 1868T>G L623W was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 154, "label": "HPO_TERM"}, {"start": 159, "end": 175, "label": "HPO_TERM"}, {"start": 196, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "Patient V2 was evaluated for a focal seizure with motor signs. The patient also presented with pallhypesthesia and a coagulopathy. Subsequent sequencing of R853W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 127, "label": "HPO_TERM"}, {"start": 154, "end": 159, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V3 were a stooped posture and an inability to coordinate gait. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 91, "label": "HPO_TERM"}, {"start": 112, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V4, who has a history of aphasia. Examination also revealed reduced reflexes on examination. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 62, "label": "HPO_TERM"}, {"start": 90, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V5 includes sluggish tendon reflexes and a stooped posture. Genetic analysis of G737R confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 89, "label": "HPO_TERM"}, {"start": 111, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V6, a patient with impaired vibratory sensation. Further investigation showed reduced reflexes on examination and an abnormality of coagulation. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 165, "label": "HPO_TERM"}, {"start": 186, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient V7 was evaluated for an ataxic gait. The patient also presented with impaired vibratory sensation and a focal motor seizure. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 42, "label": "HPO_TERM"}, {"start": 76, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 127, "label": "HPO_TERM"}, {"start": 154, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "Patient V8 was evaluated for a focal motor seizure. The patient also presented with a language disorder and a tremor. Subsequent sequencing of c.3643+2T>C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 115, "label": "HPO_TERM"}, {"start": 142, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V9, a patient with a postural or kinetic tremor. Further investigation showed a kinetic tremor and parietal sharp waves on electroencephalogram. A known variant in G737R was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 168, "label": "HPO_TERM"}, {"start": 189, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient V10 was evaluated for focal motor seizures. The patient also presented with a postural or kinetic tremor and a decrease in tendon reflexes. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 145, "label": "HPO_TERM"}, {"start": 172, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V11 were an ataxic gait and a coagulation disorder. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 84, "label": "HPO_TERM"}, {"start": 105, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient V12 was evaluated for a forward-leaning posture. The patient also presented with a focal motor seizure and a decrease in tendon reflexes. Subsequent sequencing of c.1156C>T p.R386C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V13, who has a history of an action tremor. Examination also revealed a decrease in tendon reflexes. The underlying cause was traced to a mutation in W748S.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient V14 was evaluated for a postural or kinetic tremor. The patient also presented with impaired vibratory sensation and a kinetic tremor. Subsequent sequencing of 1868T>G L623W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 138, "label": "HPO_TERM"}, {"start": 165, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient V15 was evaluated for a focal motor seizure. The patient also presented with an ataxic gait and a kinetic tremor. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 118, "label": "HPO_TERM"}, {"start": 145, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V16 were reduced vibration sense and a language disorder. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 89, "label": "HPO_TERM"}, {"start": 110, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V17, who has a history of impaired coordination during walking. Examination also revealed a blood clotting disorder. The underlying cause was traced to a mutation in 1868T>G L623W.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 118, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "Patient V18 was evaluated for parietal sharp waves on electroencephalogram. The patient also presented with a focal motor seizure and a forward-leaning posture. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 72, "label": "HPO_TERM"}, {"start": 106, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 155, "label": "HPO_TERM"}, {"start": 182, "end": 203, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V19 includes an ataxic gait and reduced reflexes on examination. Genetic analysis of R853W confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 92, "label": "HPO_TERM"}, {"start": 114, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V20 were unilateral motor seizure activity and reduced tendon reflexes. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 105, "label": "HPO_TERM"}, {"start": 126, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V21 includes focal motor seizures and gait ataxia. Genetic analysis of c.1156C>T p.R386C confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 82, "label": "HPO_TERM"}, {"start": 104, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V22 includes parietal epileptiform discharges on EEG and a blood clotting disorder. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 137, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V23, who has a history of a stooped posture. Examination also revealed hyporeflexia. The underlying cause was traced to a mutation in c3239G>C p.Ser1080Thr.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 72, "label": "HPO_TERM"}, {"start": 100, "end": 111, "label": "HPO_TERM"}, {"start": 166, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V24 were a focal motor seizure and a coagulation disorder. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 91, "label": "HPO_TERM"}, {"start": 112, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient V25 was evaluated for an ataxic gait. The patient also presented with hyporeflexia and an inability to coordinate gait. Subsequent sequencing of R853W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 120, "label": "HPO_TERM"}, {"start": 147, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V26 were hyporeflexia and impaired coordination during walking. Analysis of the W748S was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 55, "label": "HPO_TERM"}, {"start": 60, "end": 94, "label": "HPO_TERM"}, {"start": 115, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V27, a patient with a communication disorder. Further investigation showed a focal motor seizure and an action tremor. A known variant in G737R was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 142, "label": "HPO_TERM"}, {"start": 163, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V28, a patient with a stooped posture. Further investigation showed parietal epileptiform discharges on EEG and impaired vibratory sensation. A known variant in W748S was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 165, "label": "HPO_TERM"}, {"start": 186, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V29, who has a history of an action tremor. Examination also revealed a decrease in tendon reflexes. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "Patient V30 was evaluated for a deficit in vibratory sense. The patient also presented with a stooped posture and a communication disorder. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 134, "label": "HPO_TERM"}, {"start": 161, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V31 includes impaired vibratory sensation and a kinetic tremor. Genetic analysis of c. 2243G>C (p. W748S) confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 93, "label": "HPO_TERM"}, {"start": 115, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V32 were an ataxic gait and an action tremor. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 77, "label": "HPO_TERM"}, {"start": 98, "end": 115, "label": "GENE_VARIANT"}]}
{"text": "Patient V33 was evaluated for an ataxic gait. The patient also presented with an action tremor and a hunched-over stance. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 117, "label": "HPO_TERM"}, {"start": 144, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V34 were a blood clotting disorder and an elevated GGT. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 88, "label": "HPO_TERM"}, {"start": 109, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V35, a patient with EEG with parietal epileptiform discharges. Further investigation showed a kinetic tremor and an action tremor. A known variant in 15q26 118 kb deletion involving POLG1 gene and FANCI gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 155, "label": "HPO_TERM"}, {"start": 176, "end": 236, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V36, a patient with an ataxic gait. Further investigation showed a decrease in tendon reflexes and a forward-leaning posture. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 150, "label": "HPO_TERM"}, {"start": 171, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V37 were a hunched-over stance and an inability to comprehend or formulate language. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 115, "label": "HPO_TERM"}, {"start": 136, "end": 157, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V38, who has a history of an elevated GGT. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V39 includes a focal seizure with motor signs and reduced tendon reflexes. Genetic analysis of 2263A>G K755E confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 105, "label": "HPO_TERM"}, {"start": 127, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V40 includes a focal motor seizure and a stooped posture. Genetic analysis of W748S confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 87, "label": "HPO_TERM"}, {"start": 109, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V41 were focal motor seizures and impaired vibratory sensation. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 95, "label": "HPO_TERM"}, {"start": 116, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient V42 was evaluated for an ataxic gait. The patient also presented with reduced tendon reflexes and a postural or kinetic tremor. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 132, "label": "HPO_TERM"}, {"start": 159, "end": 164, "label": "GENE_VARIANT"}]}
{"text": "Patient V43 was evaluated for an ataxic gait. The patient also presented with impaired coordination during walking and a coagulation disorder. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 138, "label": "HPO_TERM"}, {"start": 165, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V44 includes parietal epileptiform discharges on EEG and a postural or kinetic tremor. Genetic analysis of 2263A>G K755E confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 117, "label": "HPO_TERM"}, {"start": 139, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V45 includes reduced vibration sense and a language disorder. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 91, "label": "HPO_TERM"}, {"start": 113, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V46 includes aphasia and a deficit in vibratory sense. Genetic analysis of W748S confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 84, "label": "HPO_TERM"}, {"start": 106, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V47, who has a history of a forward-leaning posture. Examination also revealed impaired vibratory sensation. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V48 were an elevated GGT and a forward-leaning posture. Analysis of the W748S was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 87, "label": "HPO_TERM"}, {"start": 108, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "Patient V49 was evaluated for an abnormality of coagulation. The patient also presented with parietal sharp waves on electroencephalogram and reduced tendon reflexes. Subsequent sequencing of c3239G>C p.Ser1080Thr revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 58, "label": "HPO_TERM"}, {"start": 92, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 162, "label": "HPO_TERM"}, {"start": 189, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V50 were a stooped posture and aphasia. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 72, "label": "HPO_TERM"}, {"start": 93, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "Patient V51 was evaluated for a deficit in vibratory sense. The patient also presented with an elevated GGT and a communication disorder. Subsequent sequencing of R853W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 132, "label": "HPO_TERM"}, {"start": 159, "end": 164, "label": "GENE_VARIANT"}]}
{"text": "Patient V52 was evaluated for parietal epileptiform discharges on EEG. The patient also presented with a coagulation disorder and reduced vibration sense. Subsequent sequencing of G737R revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 152, "label": "HPO_TERM"}, {"start": 179, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V53, a patient with unsteady walking. Further investigation showed a kinetic tremor and reduced tendon reflexes. A known variant in c.2794C>T p.H932Y was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 138, "label": "HPO_TERM"}, {"start": 159, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V54, who has a history of an action tremor. Examination also revealed reduced tendon reflexes. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V55 were parietal epileptiform discharges on EEG and gait ataxia. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 99, "label": "HPO_TERM"}, {"start": 120, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient V56 was evaluated for hyporeflexia. The patient also presented with parietal sharp waves on electroencephalogram and an elevated GGT. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 136, "label": "HPO_TERM"}, {"start": 163, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V57, a patient with a language disorder. Further investigation showed a coagulation disorder and reduced tendon reflexes. A known variant in G737R was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 66, "label": "HPO_TERM"}, {"start": 97, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 147, "label": "HPO_TERM"}, {"start": 168, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V58, who has a history of a deficit in vibratory sense. Examination also revealed a forward-leaning posture. The underlying cause was traced to a mutation in G737R.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient V59 was evaluated for a focal motor seizure. The patient also presented with gait ataxia and parietal sharp waves on electroencephalogram. Subsequent sequencing of c.1156C>T p.R386C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V60, who has a history of a blood clotting disorder. Examination also revealed a stooped posture. The underlying cause was traced to a mutation in W748S.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient V61 was evaluated for reduced tendon reflexes. The patient also presented with an elevated GGT and a forward-leaning posture. Subsequent sequencing of W748S revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 101, "label": "HPO_TERM"}, {"start": 106, "end": 130, "label": "HPO_TERM"}, {"start": 157, "end": 162, "label": "GENE_VARIANT"}]}
{"text": "Patient V62 was evaluated for focal motor seizures. The patient also presented with an elevated GGT and impaired vibratory sensation. Subsequent sequencing of R853W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 129, "label": "HPO_TERM"}, {"start": 156, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient V63 was evaluated for an ataxic gait. The patient also presented with reduced tendon reflexes and a stooped posture. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 121, "label": "HPO_TERM"}, {"start": 148, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient V64 was evaluated for an ataxic gait. The patient also presented with aphasia and a focal motor seizure. Subsequent sequencing of W748S revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 109, "label": "HPO_TERM"}, {"start": 136, "end": 141, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V65, who has a history of an elevated GGT. Examination also revealed hyporeflexia. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 109, "label": "HPO_TERM"}, {"start": 164, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient V66 was evaluated for parietal epileptiform discharges on EEG. The patient also presented with an elevated GGT and an action tremor. Subsequent sequencing of c3239G>C p.Ser1080Thr revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 137, "label": "HPO_TERM"}, {"start": 164, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V67 were a language disorder and a forward-leaning posture. Analysis of the 15q26 118 kb deletion involving POLG1 gene and FANCI gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 91, "label": "HPO_TERM"}, {"start": 112, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "Patient V68 was evaluated for hyporeflexia. The patient also presented with an elevated GGT and parietal epileptiform discharges on EEG. Subsequent sequencing of 15q26 118 kb deletion involving POLG1 gene and FANCI gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 133, "label": "HPO_TERM"}, {"start": 160, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V69 were aphasia and EEG with parietal epileptiform discharges. Analysis of the A467T was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 96, "label": "HPO_TERM"}, {"start": 117, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient V70 was evaluated for a stooped posture. The patient also presented with a kinetic tremor and a language disorder. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 119, "label": "HPO_TERM"}, {"start": 146, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V71 were parietal epileptiform discharges on EEG and a postural or kinetic tremor. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 115, "label": "HPO_TERM"}, {"start": 136, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V72 were a language disorder and a postural or kinetic tremor. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 94, "label": "HPO_TERM"}, {"start": 115, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "Patient V73 was evaluated for an elevated GGT. The patient also presented with a focal motor seizure and a language disorder. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 121, "label": "HPO_TERM"}, {"start": 148, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V74 were a language disorder and a stooped posture. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 83, "label": "HPO_TERM"}, {"start": 104, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "Patient V75 was evaluated for an ataxic gait. The patient also presented with a kinetic tremor and a stooped posture. Subsequent sequencing of 15q26 118 kb deletion involving POLG1 gene and FANCI gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 93, "label": "HPO_TERM"}, {"start": 98, "end": 114, "label": "HPO_TERM"}, {"start": 141, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V76 were an elevated GGT and a forward-leaning posture. Analysis of the G737R was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 87, "label": "HPO_TERM"}, {"start": 108, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V77 were parietal epileptiform discharges on EEG and a forward-leaning posture. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 112, "label": "HPO_TERM"}, {"start": 133, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V78, who has a history of an elevated GGT. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V79 includes an elevated GGT and a forward-leaning posture. Genetic analysis of c.3643+2T>C confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 89, "label": "HPO_TERM"}, {"start": 111, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V80, who has a history of a forward-leaning posture. Examination also revealed impaired vibratory sensation. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "Patient V81 was evaluated for a kinetic tremor. The patient also presented with impaired vibratory sensation and a deficit in vibratory sense. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 137, "label": "HPO_TERM"}, {"start": 164, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "Patient V82 was evaluated for an ataxic gait. The patient also presented with parietal epileptiform discharges on EEG and a forward-leaning posture. Subsequent sequencing of R853W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 145, "label": "HPO_TERM"}, {"start": 172, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient V83 was evaluated for reduced tendon reflexes. The patient also presented with a language disorder and an ataxic gait. Subsequent sequencing of c3239G>C p.Ser1080Thr revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 123, "label": "HPO_TERM"}, {"start": 150, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V84, who has a history of an action tremor. Examination also revealed a decrease in tendon reflexes. The underlying cause was traced to a mutation in G737R.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "Patient V85 was evaluated for a forward-leaning posture. The patient also presented with a stooped posture and parietal epileptiform discharges on EEG. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 148, "label": "HPO_TERM"}, {"start": 175, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V86 includes an ataxic gait and a focal motor seizure. Genetic analysis of 2263A>G K755E confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 84, "label": "HPO_TERM"}, {"start": 106, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V87 includes an ataxic gait and parietal epileptiform discharges on EEG. Genetic analysis of W748S confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 103, "label": "HPO_TERM"}, {"start": 125, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V88 includes an elevated GGT and a hunched-over stance. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 85, "label": "HPO_TERM"}, {"start": 107, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V89 were reduced vibration sense and focal motor seizures. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 91, "label": "HPO_TERM"}, {"start": 112, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V90, who has a history of an elevated GGT. Examination also revealed a deficit in vibratory sense. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient V91 was evaluated for a stooped posture. The patient also presented with an ataxic gait and a coagulation disorder. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 93, "label": "HPO_TERM"}, {"start": 98, "end": 120, "label": "HPO_TERM"}, {"start": 147, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient V92 was evaluated for impaired vibratory sensation. The patient also presented with reduced tendon reflexes and a forward-leaning posture. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V93 were a stooped posture and a postural or kinetic tremor. Analysis of the 15q26 118 kb deletion involving POLG1 gene and FANCI gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 92, "label": "HPO_TERM"}, {"start": 113, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V94, a patient with reduced reflexes on examination. Further investigation showed an ataxic gait and a forward-leaning posture. A known variant in G737R was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 76, "label": "HPO_TERM"}, {"start": 107, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 149, "label": "HPO_TERM"}, {"start": 170, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V95, who has a history of a forward-leaning posture. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V96 were aphasia and a focal motor seizure. Analysis of the R853W was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 76, "label": "HPO_TERM"}, {"start": 97, "end": 102, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V97 includes a deficit in vibratory sense and a forward-leaning posture. Genetic analysis of c. 2243G>C (p. W748S) confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 101, "label": "HPO_TERM"}, {"start": 123, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V98 includes an elevated GGT and a coagulation disorder. Genetic analysis of c. 2243G>C (p. W748S) confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 87, "label": "HPO_TERM"}, {"start": 109, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient V99 was evaluated for an ataxic gait. The patient also presented with a coagulation disorder and reduced vibration sense. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 153, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "Patient V100 was evaluated for a deficit in vibratory sense. The patient also presented with a forward-leaning posture and an ataxic gait. Subsequent sequencing of c3239G>C p.Ser1080Thr revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 133, "label": "HPO_TERM"}, {"start": 160, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V101, who has a history of a forward-leaning posture. Examination also revealed an ataxic gait. The underlying cause was traced to a mutation in W748S.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V102 were a stooped posture and aphasia. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 73, "label": "HPO_TERM"}, {"start": 94, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "Patient V103 was evaluated for an elevated GGT. The patient also presented with an ataxic gait and a coagulation disorder. Subsequent sequencing of W748S revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 119, "label": "HPO_TERM"}, {"start": 146, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "Patient V104 was evaluated for a language disorder. The patient also presented with a coagulation disorder and reduced tendon reflexes. Subsequent sequencing of W748S revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 133, "label": "HPO_TERM"}, {"start": 160, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V105, who has a history of focal motor seizures. Examination also revealed a stooped posture. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 121, "label": "HPO_TERM"}, {"start": 176, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V106, a patient with a language disorder. Further investigation showed impaired vibratory sensation and a focal motor seizure. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 149, "label": "HPO_TERM"}, {"start": 170, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V107 were reduced tendon reflexes and a forward-leaning posture. Analysis of the 1868T>G L623W was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 97, "label": "HPO_TERM"}, {"start": 118, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient V108 was evaluated for parietal epileptiform discharges on EEG. The patient also presented with an ataxic gait and a focal motor seizure. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V109 were an elevated GGT and a focal motor seizure. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 84, "label": "HPO_TERM"}, {"start": 105, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V110, a patient with impaired coordination during walking. Further investigation showed a stooped posture and a postural or kinetic tremor. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 83, "label": "HPO_TERM"}, {"start": 114, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 162, "label": "HPO_TERM"}, {"start": 183, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V111, who has a history of an elevated GGT. Examination also revealed parietal epileptiform discharges on EEG. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V112, a patient with a forward-leaning posture. Further investigation showed a kinetic tremor and parietal sharp waves on electroencephalogram. A known variant in c.2794C>T p.H932Y was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 167, "label": "HPO_TERM"}, {"start": 188, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V113 were a coagulation disorder and parietal epileptiform discharges on EEG. Analysis of the G737R was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 111, "label": "HPO_TERM"}, {"start": 132, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient V114 was evaluated for a language disorder. The patient also presented with a focal motor seizure and EEG with parietal epileptiform discharges. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 148, "label": "HPO_TERM"}, {"start": 175, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V115, who has a history of an elevated GGT. Examination also revealed a forward-leaning posture. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 123, "label": "HPO_TERM"}, {"start": 178, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V116 includes a focal motor seizure and a forward-leaning posture. Genetic analysis of R853W confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 96, "label": "HPO_TERM"}, {"start": 118, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "Patient V117 was evaluated for a language disorder. The patient also presented with a forward-leaning posture and an ataxic gait. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 125, "label": "HPO_TERM"}, {"start": 152, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V118 were an ataxic gait and a deficit in vibratory sense. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 89, "label": "HPO_TERM"}, {"start": 110, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "Patient V119 was evaluated for an ataxic gait. The patient also presented with a hunched-over stance and a language disorder. Subsequent sequencing of 15q26 118 kb deletion involving POLG1 gene and FANCI gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 121, "label": "HPO_TERM"}, {"start": 148, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V120 includes a language disorder and a forward-leaning posture. Genetic analysis of 2263A>G K755E confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 94, "label": "HPO_TERM"}, {"start": 116, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient V121 was evaluated for an ataxic gait. The patient also presented with a stooped posture and parietal epileptiform discharges on EEG. Subsequent sequencing of 1868T>G L623W revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 138, "label": "HPO_TERM"}, {"start": 165, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V122, a patient with impaired vibratory sensation. Further investigation showed an elevated GGT and a forward-leaning posture. A known variant in A467T was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 75, "label": "HPO_TERM"}, {"start": 106, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 149, "label": "HPO_TERM"}, {"start": 170, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V123 includes an elevated GGT and a kinetic tremor. Genetic analysis of W748S confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 82, "label": "HPO_TERM"}, {"start": 104, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V124 were aphasia and a language disorder. Analysis of the c.3643+2T>C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 75, "label": "HPO_TERM"}, {"start": 96, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V125 were an ataxic gait and a coagulation disorder. Analysis of the W748S was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 85, "label": "HPO_TERM"}, {"start": 106, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "Patient V126 was evaluated for a forward-leaning posture. The patient also presented with aphasia and a focal motor seizure. Subsequent sequencing of W748S revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 121, "label": "HPO_TERM"}, {"start": 148, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V127 includes a coagulation disorder and reduced vibration sense. Genetic analysis of R853W confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 96, "label": "HPO_TERM"}, {"start": 118, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V128, who has a history of an elevated GGT. Examination also revealed a deficit in vibratory sense. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V129 were an elevated GGT and a deficit in vibratory sense. Analysis of the G737R was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 90, "label": "HPO_TERM"}, {"start": 111, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V130, who has a history of a focal motor seizure. Examination also revealed a deficit in vibratory sense. The underlying cause was traced to a mutation in G737R.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V131, who has a history of a deficit in vibratory sense. Examination also revealed a coagulation disorder. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 83, "label": "HPO_TERM"}, {"start": 111, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V132, who has a history of impaired vibratory sensation. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in 1868T>G L623W.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 83, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V133, a patient with impaired coordination during walking. Further investigation showed a coagulation disorder and reduced tendon reflexes. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 83, "label": "HPO_TERM"}, {"start": 114, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 164, "label": "HPO_TERM"}, {"start": 185, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V134, who has a history of a forward-leaning posture. Examination also revealed a stooped posture. The underlying cause was traced to a mutation in c3239G>C p.Ser1080Thr.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "Patient V135 was evaluated for an action tremor. The patient also presented with a coagulation disorder and a forward-leaning posture. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 131, "label": "HPO_TERM"}, {"start": 158, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V136 includes aphasia and a stooped posture. Genetic analysis of G737R confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 54, "label": "HPO_TERM"}, {"start": 59, "end": 75, "label": "HPO_TERM"}, {"start": 97, "end": 102, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V137 were a hunched-over stance and a language disorder. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 88, "label": "HPO_TERM"}, {"start": 109, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V138 includes a stooped posture and a deficit in vibratory sense. Genetic analysis of A467T confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 94, "label": "HPO_TERM"}, {"start": 116, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V139 includes hyporeflexia and parietal epileptiform discharges on EEG. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 102, "label": "HPO_TERM"}, {"start": 124, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V140, a patient with parietal epileptiform discharges on EEG. Further investigation showed a kinetic tremor and an ataxic gait. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 88, "label": "HPO_TERM"}, {"start": 119, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 153, "label": "HPO_TERM"}, {"start": 174, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V141, who has a history of an elevated GGT. Examination also revealed a stooped posture. The underlying cause was traced to a mutation in A467T.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 115, "label": "HPO_TERM"}, {"start": 170, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "Patient V142 was evaluated for an ataxic gait. The patient also presented with a focal motor seizure and a forward-leaning posture. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 127, "label": "HPO_TERM"}, {"start": 154, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "Patient V143 was evaluated for an elevated GGT. The patient also presented with a coagulation disorder and reduced tendon reflexes. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 101, "label": "HPO_TERM"}, {"start": 106, "end": 129, "label": "HPO_TERM"}, {"start": 156, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V144 includes an ataxic gait and a coagulation disorder. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 87, "label": "HPO_TERM"}, {"start": 109, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V145, who has a history of a stooped posture. Examination also revealed a forward-leaning posture. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 125, "label": "HPO_TERM"}, {"start": 180, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "Patient V146 was evaluated for parietal sharp waves on electroencephalogram. The patient also presented with a forward-leaning posture and an ataxic gait. Subsequent sequencing of 15q26 118 kb deletion involving POLG1 gene and FANCI gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 73, "label": "HPO_TERM"}, {"start": 107, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 149, "label": "HPO_TERM"}, {"start": 176, "end": 236, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V147 includes reduced vibration sense and a postural or kinetic tremor. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 101, "label": "HPO_TERM"}, {"start": 123, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V148, who has a history of an elevated GGT. Examination also revealed an ataxic gait. The underlying cause was traced to a mutation in c.3643+2T>C.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 112, "label": "HPO_TERM"}, {"start": 167, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V149 were an action tremor and an ataxic gait. Analysis of the R853W was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 78, "label": "HPO_TERM"}, {"start": 99, "end": 104, "label": "GENE_VARIANT"}]}
{"text": "Patient V150 was evaluated for a deficit in vibratory sense. The patient also presented with an elevated GGT and an ataxic gait. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 123, "label": "HPO_TERM"}, {"start": 150, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "Patient V151 was evaluated for a forward-leaning posture. The patient also presented with an elevated GGT and parietal sharp waves on electroencephalogram. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 150, "label": "HPO_TERM"}, {"start": 177, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V152, who has a history of impaired coordination during walking. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in W748S.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 91, "label": "HPO_TERM"}, {"start": 119, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V153, who has a history of parietal epileptiform discharges on EEG. Examination also revealed a forward-leaning posture. The underlying cause was traced to a mutation in c.1156C>T p.R386C.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 96, "label": "HPO_TERM"}, {"start": 124, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "Patient V154 was evaluated for an ataxic gait. The patient also presented with aphasia and reduced vibration sense. Subsequent sequencing of c3239G>C p.Ser1080Thr revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 112, "label": "HPO_TERM"}, {"start": 139, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V155 were a language disorder and a forward-leaning posture. Analysis of the W748S was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 92, "label": "HPO_TERM"}, {"start": 113, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V156 were parietal epileptiform discharges on EEG and a stooped posture. Analysis of the 2263A>G K755E was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 105, "label": "HPO_TERM"}, {"start": 126, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V157 includes an ataxic gait and a coagulation disorder. Genetic analysis of G737R confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 87, "label": "HPO_TERM"}, {"start": 109, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V158, a patient with a language disorder. Further investigation showed an elevated GGT and a deficit in vibratory sense. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 143, "label": "HPO_TERM"}, {"start": 164, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient V159 was evaluated for a stooped posture. The patient also presented with parietal sharp waves on electroencephalogram and reduced tendon reflexes. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 151, "label": "HPO_TERM"}, {"start": 178, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient V160 was evaluated for a deficit in vibratory sense. The patient also presented with a stooped posture and aphasia. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 119, "label": "HPO_TERM"}, {"start": 146, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V161, who has a history of an action tremor. Examination also revealed a stooped posture. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 72, "label": "HPO_TERM"}, {"start": 100, "end": 116, "label": "HPO_TERM"}, {"start": 171, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V162 were a hunched-over stance and an action tremor. Analysis of the c.1156C>T p.R386C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 85, "label": "HPO_TERM"}, {"start": 106, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V163 includes aphasia and a focal motor seizure. Genetic analysis of 15q26 118 kb deletion involving POLG1 gene and FANCI gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 54, "label": "HPO_TERM"}, {"start": 59, "end": 79, "label": "HPO_TERM"}, {"start": 101, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V164, who has a history of a forward-leaning posture. Examination also revealed a coagulation disorder. The underlying cause was traced to a mutation in 15q26 118 kb deletion involving POLG1 gene and FANCI gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 246, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V165 includes a kinetic tremor and a deficit in vibratory sense. Genetic analysis of c. 2243G>C (p. W748S) confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 94, "label": "HPO_TERM"}, {"start": 116, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V166 were focal motor seizures and an elevated GGT. Analysis of the c.3643+2T>C was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 84, "label": "HPO_TERM"}, {"start": 105, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V167, who has a history of an elevated GGT. Examination also revealed hyporeflexia. The underlying cause was traced to a mutation in A467T.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 110, "label": "HPO_TERM"}, {"start": 165, "end": 170, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V168 includes a stooped posture and a postural or kinetic tremor. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 95, "label": "HPO_TERM"}, {"start": 117, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V169 were impaired vibratory sensation and a focal motor seizure. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 96, "label": "HPO_TERM"}, {"start": 117, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "Patient V170 was evaluated for parietal epileptiform discharges on EEG. The patient also presented with an ataxic gait and a focal motor seizure. Subsequent sequencing of 15q26 118 kb deletion involving POLG1 gene and FANCI gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 70, "label": "HPO_TERM"}, {"start": 104, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 229, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V171 includes reduced tendon reflexes and a stooped posture. Genetic analysis of 2263A>G K755E confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 91, "label": "HPO_TERM"}, {"start": 113, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V172, a patient with a postural or kinetic tremor. Further investigation showed aphasia and a deficit in vibratory sense. A known variant in c3239G>C p.Ser1080Thr was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 76, "label": "HPO_TERM"}, {"start": 107, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 145, "label": "HPO_TERM"}, {"start": 166, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "Patient V173 was evaluated for an ataxic gait. The patient also presented with a coagulation disorder and reduced vibration sense. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 127, "label": "HPO_TERM"}, {"start": 154, "end": 159, "label": "GENE_VARIANT"}]}
{"text": "Patient V174 was evaluated for a deficit in vibratory sense. The patient also presented with a language disorder and parietal epileptiform discharges on EEG. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 153, "label": "HPO_TERM"}, {"start": 180, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V175 were an ataxic gait and a coagulation disorder. Analysis of the 15q26 118 kb deletion involving POLG1 gene and FANCI gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 85, "label": "HPO_TERM"}, {"start": 106, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V176 includes an elevated GGT and a forward-leaning posture. Genetic analysis of W748S confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 90, "label": "HPO_TERM"}, {"start": 112, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "Patient V177 was evaluated for a forward-leaning posture. The patient also presented with aphasia and a focal motor seizure. Subsequent sequencing of c.3643+2T>C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 121, "label": "HPO_TERM"}, {"start": 148, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V178 were reduced tendon reflexes and a postural or kinetic tremor. Analysis of the c.2794C>T p.H932Y was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 100, "label": "HPO_TERM"}, {"start": 121, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V179, a patient with impaired vibratory sensation. Further investigation showed a postural or kinetic tremor and aphasia. A known variant in c. 2243G>C (p. W748S) was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 75, "label": "HPO_TERM"}, {"start": 106, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 145, "label": "HPO_TERM"}, {"start": 166, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V180, who has a history of an action tremor. Examination also revealed a coagulation disorder. The underlying cause was traced to a mutation in c.1156C>T p.R386C.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 72, "label": "HPO_TERM"}, {"start": 100, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient V181 was evaluated for a postural or kinetic tremor. The patient also presented with a coagulation disorder and reduced tendon reflexes. Subsequent sequencing of c.3643+2T>C revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 58, "label": "HPO_TERM"}, {"start": 92, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 142, "label": "HPO_TERM"}, {"start": 169, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V182 were parietal epileptiform discharges on EEG and a hunched-over stance. Analysis of the c. 2243G>C (p. W748S) was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 109, "label": "HPO_TERM"}, {"start": 130, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V183 includes a forward-leaning posture and an ataxic gait. Genetic analysis of c.2794C>T p.H932Y confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 89, "label": "HPO_TERM"}, {"start": 111, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient V184, a patient with focal motor seizures. Further investigation showed a forward-leaning posture and a language disorder. A known variant in G737R was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 124, "label": "HPO_TERM"}, {"start": 129, "end": 147, "label": "HPO_TERM"}, {"start": 168, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V185 were a forward-leaning posture and a focal motor seizure. Analysis of the R853W was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 115, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V186, who has a history of a forward-leaning posture. Examination also revealed parietal epileptiform discharges on EEG. The underlying cause was traced to a mutation in 15q26 118 kb deletion involving POLG1 gene and FANCI gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 263, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V187 includes an ataxic gait and an elevated GGT. Genetic analysis of c.3643+2T>C confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 79, "label": "HPO_TERM"}, {"start": 101, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "Patient V188 was evaluated for a language disorder. The patient also presented with a stooped posture and reduced tendon reflexes. Subsequent sequencing of A467T revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 127, "label": "HPO_TERM"}, {"start": 154, "end": 159, "label": "GENE_VARIANT"}]}
{"text": "Patient V189 was evaluated for an ataxic gait. The patient also presented with an elevated GGT and a coagulation disorder. Subsequent sequencing of c. 2243G>C (p. W748S) revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 119, "label": "HPO_TERM"}, {"start": 146, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "Patient V190 was evaluated for a deficit in vibratory sense. The patient also presented with an ataxic gait and a hunched-over stance. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 57, "label": "HPO_TERM"}, {"start": 91, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 129, "label": "HPO_TERM"}, {"start": 156, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient V191 were aphasia and a focal motor seizure. Analysis of the c3239G>C p.Ser1080Thr was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 98, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V192, who has a history of an elevated GGT. Examination also revealed a focal motor seizure. The underlying cause was traced to a mutation in c. 2243G>C (p. W748S).", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 119, "label": "HPO_TERM"}, {"start": 174, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V193 includes a focal motor seizure and a forward-leaning posture. Genetic analysis of 1868T>G L623W confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 96, "label": "HPO_TERM"}, {"start": 118, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V194 includes reduced vibration sense and a coagulation disorder. Genetic analysis of 15q26 118 kb deletion involving POLG1 gene and FANCI gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 96, "label": "HPO_TERM"}, {"start": 118, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient V195 was evaluated for a focal motor seizure. The patient also presented with a coagulation disorder and reduced vibration sense. Subsequent sequencing of 2263A>G K755E revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 134, "label": "HPO_TERM"}, {"start": 161, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V196, who has a history of reduced vocal volume. Examination also revealed unintentional weight loss. The underlying cause was traced to a mutation in c.2794C>T p.H932Y.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 130, "label": "HPO_TERM"}, {"start": 185, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient V197 includes bilateral grand mal seizures and weight loss. Genetic analysis of c3239G>C p.Ser1080Thr confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 91, "label": "HPO_TERM"}, {"start": 117, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient V198, who has a history of reduced vocal volume. Examination also revealed a diagnosis of focal-onset seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "Patient V199 was evaluated for an action tremor. The patient also presented with a focal motor seizure and aphasia. Subsequent sequencing of c.2794C>T p.H932Y revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 112, "label": "HPO_TERM"}, {"start": 139, "end": 158, "label": "GENE_VARIANT"}]}
